这是一篇来自已证抗体库的有关小鼠 Mapk1的综述,是根据556篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Mapk1 抗体。
Mapk1 同义词: 9030612K14Rik; AA407128; AU018647; C78273; ERK; Erk2; MAPK2; PRKM2; Prkm1; p41mapk; p42mapk

圣克鲁斯生物技术
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 图 2b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc1647)被用于被用于免疫印迹在小鼠样本上 (图 2b). Front Immunol (2020) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:3000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:3000. elife (2020) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 人类; 1:1000; 图 6b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-81492)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6b). Antioxidants (Basel) (2020) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:1000; 图 6b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6b). Antioxidants (Basel) (2020) ncbi
小鼠 单克隆(E-4)
  • 免疫组化; 人类; 1:200; 图 3
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫组化在人类样本上浓度为1:200 (图 3) 和 被用于免疫印迹在人类样本上 (图 6). Eur J Histochem (2020) ncbi
小鼠 单克隆
  • 免疫印迹; 小鼠; 图 s3b
  • 免疫印迹; 人类; 图 s3b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在小鼠样本上 (图 s3b) 和 被用于免疫印迹在人类样本上 (图 s3b). Nature (2019) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5a). Oncogene (2020) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:1000; 图 3c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). Oncol Lett (2019) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:200; 图 4s2a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC7383)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 4s2a). elife (2019) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:2000; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 6a). Front Endocrinol (Lausanne) (2019) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 人类; 1:2000; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-81492)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 6a). Front Endocrinol (Lausanne) (2019) ncbi
小鼠 单克隆(33)
  • 免疫沉淀; 人类; 图 3d
  • 免疫印迹; 人类; 图 2b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136288)被用于被用于免疫沉淀在人类样本上 (图 3d) 和 被用于免疫印迹在人类样本上 (图 2b). Oncogenesis (2019) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:200; 图 3c, 3d, s8b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 3c, 3d, s8b). Science (2019) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 s3a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514302)被用于被用于免疫印迹在人类样本上 (图 s3a). Sci Adv (2019) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 大鼠; 图 3c
圣克鲁斯生物技术 Mapk1抗体(Santa, sc-135,900)被用于被用于免疫印迹在大鼠样本上 (图 3c). BMC Complement Altern Med (2019) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:5000; 图 1c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 1c). Nat Commun (2019) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:1000; 图 1b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514,302)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1b). EBioMedicine (2019) ncbi
小鼠 单克隆(12A4)
  • 免疫印迹; 小鼠; 图 2d
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术 Mapk1抗体(Santa, sc-81457)被用于被用于免疫印迹在小鼠样本上 (图 2d) 和 被用于免疫印迹在人类样本上 (图 3a). Oncogene (2019) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 2e
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514302)被用于被用于免疫印迹在人类样本上 (图 2e). Exp Mol Med (2018) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 图 3g, s7c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在小鼠样本上 (图 3g, s7c). Cell (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 8a
圣克鲁斯生物技术 Mapk1抗体(santa cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 8a). J Exp Med (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 4d
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology Inc, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 4d). J Clin Invest (2018) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠; 1:1000; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). Restor Neurol Neurosci (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). Restor Neurol Neurosci (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, E-4)被用于被用于免疫印迹在人类样本上 (图 2b). Cell Death Dis (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5a
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, E-4)被用于被用于免疫印迹在人类样本上 (图 5a). Cell Res (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 6d
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology Inc, SC-7383)被用于被用于免疫印迹在小鼠样本上 (图 6d). Neurotherapeutics (2018) ncbi
小鼠 单克隆(12D4)
  • 免疫组化-冰冻切片; 小鼠; 1:20; 图 s6f
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-81492)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:20 (图 s6f). Nat Commun (2018) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 图 3b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在人类样本上 (图 3b). Int J Oncol (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5). Mol Med Rep (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6a). Oncotarget (2017) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 图 7a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在人类样本上 (图 7a). Cancer Lett (2017) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 1:1000; 图 s7a
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-1647)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s7a). Nat Commun (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 3g
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, SC-7383)被用于被用于免疫印迹在小鼠样本上 (图 3g). J Exp Med (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3e
圣克鲁斯生物技术 Mapk1抗体(SCB, E-4)被用于被用于免疫印迹在人类样本上 (图 3e). Cancer Res (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 3c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). Oncol Lett (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 4b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 4b). J Exp Med (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6a). Exp Mol Med (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在人类样本上 (图 6a). Exp Mol Med (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 6A
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在人类样本上 (图 6A). Sci Rep (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 6
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 6). J Ethnopharmacol (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 2b
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2b). Toxicol In Vitro (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:200; 图 2b
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 2b). Toxicol In Vitro (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 2b
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2b). J Steroid Biochem Mol Biol (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:2000; 图 4a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4a). Exp Ther Med (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 1a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, D-2)被用于被用于免疫印迹在人类样本上 (图 1a). Nucleic Acids Res (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 2e
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2e). Nat Commun (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 1c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在人类样本上 (图 1c). Mol Carcinog (2017) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 1a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, D2)被用于被用于免疫印迹在人类样本上 (图 1a). J Biol Chem (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫组化-石蜡切片; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫组化-石蜡切片在小鼠样本上. Acta Histochem (2017) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:1000; 图 1a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1a). Int J Cancer (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5b). Int J Mol Med (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠; 图 3a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在小鼠样本上 (图 3a). Int J Mol Sci (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 图 6b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, Sc-7383)被用于被用于免疫印迹在大鼠样本上 (图 6b). Physiol Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1500; 图 4a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1500 (图 4a). Oncol Lett (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:1500; 图 4a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:1500 (图 4a). Oncol Lett (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 小鼠; 图 3
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, SC-514302)被用于被用于免疫印迹在小鼠样本上 (图 3). Blood Cancer J (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 3
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, SC-7383)被用于被用于免疫印迹在小鼠样本上 (图 3). Blood Cancer J (2016) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫组化-石蜡切片; 人类; 图 7a
  • 免疫印迹; 人类; 1:500; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫组化-石蜡切片在人类样本上 (图 7a) 和 被用于免疫印迹在人类样本上浓度为1:500 (图 5a). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 表 1
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (表 1). J Neuroinflammation (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6e
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, 7383)被用于被用于免疫印迹在人类样本上 (图 6e). Am J Physiol Heart Circ Physiol (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 4b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 4b). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). Mol Cell Biochem (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 3a). J Cereb Blood Flow Metab (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 7a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 7a). J Immunol (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 4). Mol Ther Methods Clin Dev (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:1000; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 1:1000; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在人类样本上 (图 5). Cell Rep (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 1a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上 (图 1a). J Biol Chem (2016) ncbi
小鼠 单克隆(12A4)
  • 免疫沉淀; 大鼠; 图 5c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-81457)被用于被用于免疫沉淀在大鼠样本上 (图 5c). PLoS ONE (2016) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 大鼠; 图 5c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-136521)被用于被用于免疫印迹在大鼠样本上 (图 5c). PLoS ONE (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:1000; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2). Cell Death Dis (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 3). Oncol Lett (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 2a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 2a). J Cell Biol (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 2a). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3h
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E4)被用于被用于免疫印迹在人类样本上 (图 3h). Genes Cancer (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 图 6b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上 (图 6b). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 5d
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5d). Oncotarget (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:200; 图 6A
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 6A). Front Pharmacol (2016) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 1:200; 图 6A
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 6A). Front Pharmacol (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 图 1
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在小鼠样本上 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:1000; 图 s4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s4). Nat Commun (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc1647)被用于被用于免疫印迹在人类样本上 (图 5a). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠; 1:1000; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 1:500; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, 7383)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 5a). Int J Endocrinol (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 7c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 7c). J Biol Chem (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc7383)被用于被用于免疫印迹在人类样本上 (图 4). BMC Complement Altern Med (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc1647)被用于被用于免疫印迹在人类样本上 (图 4). BMC Complement Altern Med (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 s2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在小鼠样本上 (图 s2). Sci Rep (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:500; 图 3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3). Oncoimmunology (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6a). J Immunol Res (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:200; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 5). Genes Cancer (2016) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 1:200; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 5). Genes Cancer (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5). BMC Cancer (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 2). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫细胞化学; 小鼠; 1:50; 图 5
  • 免疫组化; 小鼠; 1:50; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫细胞化学在小鼠样本上浓度为1:50 (图 5) 和 被用于免疫组化在小鼠样本上浓度为1:50 (图 5). Nat Commun (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 3c). Oncotarget (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 大鼠; 图 10a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在大鼠样本上 (图 10a). Int J Mol Med (2016) ncbi
小鼠 单克隆
  • 免疫组化; 小鼠; 1:500; 图 3d
  • 免疫印迹; 小鼠; 1:500; 图 3d
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫组化在小鼠样本上浓度为1:500 (图 3d) 和 被用于免疫印迹在小鼠样本上浓度为1:500 (图 3d). J Neurosci (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 5
  • 免疫印迹; 人类; 图 8
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, E-4)被用于被用于免疫印迹在小鼠样本上 (图 5) 和 被用于免疫印迹在人类样本上 (图 8). J Exp Med (2016) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 大鼠; 1:500; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-81492)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 6). Exp Ther Med (2016) ncbi
小鼠 单克隆(C-8)
  • 免疫印迹; 小鼠; 图 8f
圣克鲁斯生物技术 Mapk1抗体(santa cruz, C-8)被用于被用于免疫印迹在小鼠样本上 (图 8f). Front Endocrinol (Lausanne) (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠; 1:1000; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). Sci Rep (2016) ncbi
小鼠 单克隆(12D4)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 5
  • 免疫印迹; 小鼠; 1:1000; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-81492)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 5) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). Sci Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 7e
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 7e). J Immunol (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 图 1d
  • 免疫组化; 小鼠; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc7383)被用于被用于免疫印迹在大鼠样本上 (图 1d) 和 被用于免疫组化在小鼠样本上 (图 7). J Cell Mol Med (2016) ncbi
小鼠 单克隆(E-4)
  • 酶联免疫吸附测定; 人类; 1:500; 图 10
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于酶联免疫吸附测定在人类样本上浓度为1:500 (图 10). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 7). Oncotarget (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上 (图 7). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 1:500; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruze, sc-7383)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 6). PLoS ONE (2016) ncbi
小鼠 单克隆(12A4)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc81457)被用于被用于免疫印迹在人类样本上 (图 2). Breast Cancer Res (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 3
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 3). Drug Des Devel Ther (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 1:2000; 图 s3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 s3). Clin Cancer Res (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 10
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 10). J Neuroinflammation (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 s7
  • 免疫印迹; 小鼠; 1:1000; 图 2
  • 免疫印迹; 人类; 1:1000; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 s7), 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2). Nat Commun (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5c). Mol Cells (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5a). Apoptosis (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 S3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 S3). Oncotarget (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上 (图 3). Biomed Res Int (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 7). Oncotarget (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 s3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 s3). J Immunol Res (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫组化; 非洲爪蛙; 1:50; 图 5
  • 免疫细胞化学; 小鼠; 1:200; 图 2
  • 免疫印迹; 小鼠; 1:1000; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, D-2)被用于被用于免疫组化在非洲爪蛙样本上浓度为1:50 (图 5), 被用于免疫细胞化学在小鼠样本上浓度为1:200 (图 2) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 8
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在人类样本上 (图 8). Oncotarget (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6a). Oncogene (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC7383)被用于被用于免疫印迹在人类样本上. Int J Cancer (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 1:2000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上浓度为1:2000. Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3c
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 3c). Oncogene (2016) ncbi
小鼠 单克隆(H-9)
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-271451)被用于被用于免疫印迹在人类样本上 (图 3a). Cancer Cell Int (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:8000; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-135900)被用于被用于免疫印迹在人类样本上浓度为1:8000 (图 7). Int J Mol Sci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; pigs ; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在pigs 样本上 (图 2). J Immunol (2015) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 人类; 图 6b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-81492)被用于被用于免疫印迹在人类样本上 (图 6b). BMC Cancer (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 3). Cancer Sci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Cardiovasc Res (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Laboratories, SC7383)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 6b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E-4)被用于被用于免疫印迹在小鼠样本上 (图 6b). J Exp Med (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在大鼠样本上浓度为1:1000. Int J Neuropsychopharmacol (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫组化-自由浮动切片; 大鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫组化-自由浮动切片在大鼠样本上. Free Radic Biol Med (2015) ncbi
小鼠 单克隆(33)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136288)被用于被用于免疫印迹在人类样本上浓度为1:500. Mol Med Rep (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 2). J Biomed Sci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-7383)被用于被用于免疫印迹在小鼠样本上. Virol Sin (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa-Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6). PLoS Pathog (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在小鼠样本上. Neuropharmacology (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上. Neuropharmacology (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 图 4d
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-135900)被用于被用于免疫印迹在人类样本上 (图 4d). Oncotarget (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-135900)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Cancer Res (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 图 s4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在小鼠样本上 (图 s4). Br J Cancer (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 s8
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 s8). Autophagy (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-7383)被用于被用于免疫印迹在人类样本上 (图 7). PLoS ONE (2015) ncbi
小鼠 单克隆(MK1)
  • 染色质免疫沉淀 ; 人类; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotech, sc-135900)被用于被用于染色质免疫沉淀 在人类样本上 (图 6). PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:500. Neuroscience (2015) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-81492)被用于被用于免疫印迹在小鼠样本上. J Nutr Biochem (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-135900)被用于被用于免疫印迹在小鼠样本上. J Nutr Biochem (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在大鼠样本上 (图 5). Mar Drugs (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-7383)被用于被用于免疫印迹在人类样本上 (图 5). Br J Nutr (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 1:500; 图 4g
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 4g). J Cell Sci (2015) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-136521)被用于被用于免疫印迹在人类样本上 (图 6). Curr Mol Med (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E-4)被用于被用于免疫印迹在人类样本上. Cell Mol Life Sci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500. Cell Signal (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上 (图 1). Nucleic Acids Res (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 2
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 小鼠; 1:500; 图 4a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-81492)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4a). Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5f
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5f). Cell Commun Signal (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4). Nat Commun (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫细胞化学; 小鼠
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnologies, SC-7383)被用于被用于免疫细胞化学在小鼠样本上 和 被用于免疫印迹在小鼠样本上. Endocrinology (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 s21
圣克鲁斯生物技术 Mapk1抗体(Santa, sc-7383)被用于被用于免疫印迹在人类样本上 (图 s21). PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000. Exp Ther Med (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-135900)被用于被用于免疫印迹在人类样本上. Mutat Res (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫沉淀; 人类; 图 3
  • 免疫印迹; 人类; 图 s9
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, sc-7383)被用于被用于免疫沉淀在人类样本上 (图 3) 和 被用于免疫印迹在人类样本上 (图 s9). Cell Death Differ (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫沉淀; 人类; 图 3
  • 免疫细胞化学; 人类; 图 3
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, sc-1647)被用于被用于免疫沉淀在人类样本上 (图 3), 被用于免疫细胞化学在人类样本上 (图 3) 和 被用于免疫印迹在人类样本上 (图 4). Cell Death Differ (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Mol Cell Endocrinol (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上. Leuk Lymphoma (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Leuk Lymphoma (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在大鼠样本上浓度为1:200. PLoS ONE (2015) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在大鼠样本上浓度为1:200. PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E4)被用于被用于免疫印迹在人类样本上 (图 2). Cell Res (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 2). Cell Cycle (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 2b). Environ Health Perspect (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC7383)被用于被用于免疫印迹在小鼠样本上浓度为1:200. Mol Cell Biol (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, E-4)被用于被用于免疫印迹在人类样本上 (图 1). J Biol Chem (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Oncotarget (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫组化; 人类; 1:100
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫组化在人类样本上浓度为1:100. Cancer Lett (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫细胞化学; 人类; 1:200
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-1647)被用于被用于免疫细胞化学在人类样本上浓度为1:200 和 被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-81492)被用于被用于免疫印迹在大鼠样本上浓度为1:200. Life Sci (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在大鼠样本上浓度为1:200. Life Sci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E-4)被用于被用于免疫印迹在人类样本上浓度为1:1000. Tumour Biol (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Nat Neurosci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 大鼠; 图 3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在大鼠样本上 (图 3). Biochem Pharmacol (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000. Exp Cell Res (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:1000. Exp Cell Res (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Oncotarget (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, 7383)被用于被用于免疫印迹在人类样本上 (图 1). Cell Cycle (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:500; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 2). Nat Commun (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:1000. J Biol Chem (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000. J Biol Chem (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫组化-石蜡切片; 大鼠
  • 免疫印迹; 大鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, E-4, sc-7383)被用于被用于免疫组化-石蜡切片在大鼠样本上 和 被用于免疫印迹在大鼠样本上. Hippocampus (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:800
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-135900)被用于被用于免疫印迹在人类样本上浓度为1:800. Growth Factors (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; kangaroo rats; 1:200; 图 2
圣克鲁斯生物技术 Mapk1抗体(santa cruz, sc-7383)被用于被用于免疫印迹在kangaroo rats样本上浓度为1:200 (图 2). Cell Mol Neurobiol (2015) ncbi
小鼠 单克隆(12D4)
  • 免疫细胞化学; 人类; 1:300
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotech, sc-81492)被用于被用于免疫细胞化学在人类样本上浓度为1:300. Biores Open Access (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上. Biometals (2014) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-1647)被用于被用于免疫印迹在人类样本上. Cancer Res (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-135900)被用于被用于免疫印迹在小鼠样本上. J Am Heart Assoc (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上. J Virol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000. BMC Cancer (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫组化-石蜡切片; 人类; 1:100
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc7383)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. J Gastroenterol Hepatol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 牛
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在牛样本上. Biomed Res Int (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Angiogenesis (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Int J Oncol (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上. Int J Oncol (2014) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-1647)被用于被用于免疫印迹在人类样本上. Pigment Cell Melanoma Res (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; domestic rabbit; 1:1,000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在domestic rabbit样本上浓度为1:1,000. Stem Cells Dev (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上. Mol Cell Endocrinol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Mol Cancer Ther (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 1
圣克鲁斯生物技术 Mapk1抗体(Santa, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Mol Cancer Ther (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上. Oncogene (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-7383)被用于被用于免疫印迹在人类样本上. Biochem Pharmacol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc7383)被用于被用于免疫印迹在人类样本上. Mol Cell Biol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上. Electrophoresis (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上. Exp Mol Med (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 番茄
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-7383)被用于被用于免疫印迹在番茄样本上. J Agric Food Chem (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E-4)被用于被用于免疫印迹在人类样本上浓度为1:1000. Mol Cancer Res (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫细胞化学; 大鼠
  • 免疫印迹; 大鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫细胞化学在大鼠样本上 和 被用于免疫印迹在大鼠样本上. Glia (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-136521)被用于被用于免疫印迹在大鼠样本上浓度为1:200. Exp Cell Res (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在大鼠样本上浓度为1:200. Exp Cell Res (2014) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, D2)被用于被用于免疫印迹在人类样本上. J Biol Chem (2013) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上. Cancer Cell Int (2013) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500. Mol Neurodegener (2012) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上浓度为1:500. Mol Neurodegener (2012) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上浓度为1:500. J Neuroimmunol (2013) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500. J Neuroimmunol (2013) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在大鼠样本上. Lab Anim Res (2012) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 1:1000; 图 3b
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, E-4)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3b). Am J Physiol Gastrointest Liver Physiol (2011) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5). Leukemia (2011) ncbi
西格玛奥德里奇
小鼠 单克隆(MAPK-YT)
  • 免疫组化; Ciona; 1:500; 图 2d
西格玛奥德里奇 Mapk1抗体(Sigma, M9692)被用于被用于免疫组化在Ciona样本上浓度为1:500 (图 2d). Front Cell Dev Biol (2020) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 2e
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M8159)被用于被用于免疫印迹在人类样本上 (图 2e). Theranostics (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6i
西格玛奥德里奇 Mapk1抗体(Sigma Aldrich, M5670)被用于被用于免疫印迹在人类样本上 (图 6i). elife (2020) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 6i
西格玛奥德里奇 Mapk1抗体(Sigma Aldrich, M8159)被用于被用于免疫印迹在人类样本上 (图 6i). elife (2020) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 1:10,000; 图 s1c
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M8159)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 s1c). Nat Commun (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:10,000; 图 s1b
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M5670)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 s1b). Nat Commun (2020) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 3b
西格玛奥德里奇 Mapk1抗体(Sigma, M9692)被用于被用于免疫印迹在人类样本上 (图 3b). Cancer Cell (2019) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 小鼠; 1:1000; 图 4c
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M8159)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4c). EMBO J (2019) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 大鼠; 图 5a
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M8159)被用于被用于免疫印迹在大鼠样本上 (图 5a). Cell Death Dis (2018) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 2c
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M8159)被用于被用于免疫印迹在人类样本上 (图 2c). Breast Cancer Res Treat (2018) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化; 小鼠; 图 s5d
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫组化在小鼠样本上 (图 s5d). Science (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:2000; 图 4b
西格玛奥德里奇 Mapk1抗体(Sigma Aldrich, M5670)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4b). Nat Commun (2017) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 1:500; 图 4b
西格玛奥德里奇 Mapk1抗体(Sigma Aldrich, M8159)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4b). Nat Commun (2017) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 1:1000; 图 4d
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4d). Mol Cell Biochem (2017) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化; 斑马鱼; 1:500; 图 5I''
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M8159)被用于被用于免疫组化在斑马鱼样本上浓度为1:500 (图 5I''). elife (2017) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫细胞化学; 小鼠; 图 1a
  • 免疫印迹; 小鼠; 图 1c
西格玛奥德里奇 Mapk1抗体(sigma, M9692)被用于被用于免疫细胞化学在小鼠样本上 (图 1a) 和 被用于免疫印迹在小鼠样本上 (图 1c). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 表 4
西格玛奥德里奇 Mapk1抗体(Sigma, M5670)被用于被用于免疫印迹在人类样本上 (表 4). Transl Psychiatry (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 表 4
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在人类样本上 (表 4). Transl Psychiatry (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; fruit fly ; 1:2000; 图 s8a
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在fruit fly 样本上浓度为1:2000 (图 s8a). Nat Commun (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 3c
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M8159)被用于被用于免疫印迹在人类样本上 (图 3c). J Biol Chem (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; pigs ; 图 1b
西格玛奥德里奇 Mapk1抗体(Sigma, M9692)被用于被用于免疫印迹在pigs 样本上 (图 1b). Arthritis Rheumatol (2017) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 4b
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在人类样本上 (图 4b). Oncotarget (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 非洲爪蛙; 1:5000; 图 2f
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在非洲爪蛙样本上浓度为1:5000 (图 2f). Open Biol (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 7e
西格玛奥德里奇 Mapk1抗体(Sigma, MAPK-YT)被用于被用于免疫印迹在人类样本上 (图 7e). J Biol Chem (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 1:10,000; 图 2a
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 2a). Dig Dis Sci (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 3
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在人类样本上 (图 3). J Biol Chem (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 小鼠; 图 7
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在小鼠样本上 (图 7). elife (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:2000; 图 5
西格玛奥德里奇 Mapk1抗体(Sigma, M5670)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3b
西格玛奥德里奇 Mapk1抗体(Sigma, M5670)被用于被用于免疫印迹在人类样本上 (图 3b). Mol Cell Proteomics (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:10,000; 图 5
西格玛奥德里奇 Mapk1抗体(Sigma, M 5670)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 5). Oncotarget (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 1:1000; 图 5
西格玛奥德里奇 Mapk1抗体(Sigma, M 8159)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:40,000; 图 s2a
西格玛奥德里奇 Mapk1抗体(Sigma, M5670)被用于被用于免疫印迹在大鼠样本上浓度为1:40,000 (图 s2a). Metallomics (2016) ncbi
domestic rabbit 多克隆
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M5670)被用于. Nat Commun (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 犬; 图 1d
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在犬样本上 (图 1d). BMC Genomics (2015) ncbi
domestic rabbit 多克隆
西格玛奥德里奇 Mapk1抗体(Sigma, M5670)被用于. BMC Genomics (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫细胞化学; 小鼠; 1:500; 图 1
  • 免疫印迹; 小鼠; 1:2000; 图 2
西格玛奥德里奇 Mapk1抗体(Sigma, M9692)被用于被用于免疫细胞化学在小鼠样本上浓度为1:500 (图 1) 和 被用于免疫印迹在小鼠样本上浓度为1:2000 (图 2). PLoS ONE (2015) ncbi
domestic rabbit 多克隆
西格玛奥德里奇 Mapk1抗体(Sigma Chemical Co, M5670)被用于. J Biol Chem (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; fruit fly ; 1:500
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在fruit fly 样本上浓度为1:500. Development (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化-石蜡切片; fruit fly ; 1:200; 图 2
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫组化-石蜡切片在fruit fly 样本上浓度为1:200 (图 2). Nat Cell Biol (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化-冰冻切片; 斑马鱼; 1:50; 图 s5
西格玛奥德里奇 Mapk1抗体(Sigma, M9692)被用于被用于免疫组化-冰冻切片在斑马鱼样本上浓度为1:50 (图 s5). PLoS ONE (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 s5
西格玛奥德里奇 Mapk1抗体(Sigma, M9692)被用于被用于免疫印迹在人类样本上 (图 s5). Proc Natl Acad Sci U S A (2015) ncbi
domestic rabbit 多克隆
西格玛奥德里奇 Mapk1抗体(Sigma, M5670)被用于. Int J Mol Med (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 8
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在人类样本上 (图 8). Oncotarget (2015) ncbi
domestic rabbit 多克隆
西格玛奥德里奇 Mapk1抗体(Sigma, M-5670)被用于. Oncotarget (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 5
西格玛奥德里奇 Mapk1抗体(Sigma, 8159)被用于被用于免疫印迹在人类样本上 (图 5). Cancer Cell (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 小鼠; 图 4
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在小鼠样本上 (图 4). Proc Natl Acad Sci U S A (2015) ncbi
domestic rabbit 多克隆
西格玛奥德里奇 Mapk1抗体(Sigma, M 5670)被用于. Nat Commun (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类
西格玛奥德里奇 Mapk1抗体(Sigma, M-9692)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 s4
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在人类样本上 (图 s4). J Cell Sci (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化; fruit fly ; 1:200
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫组化在fruit fly 样本上浓度为1:200. PLoS ONE (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 小鼠; 图 2
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在小鼠样本上 (图 2). EMBO J (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 大鼠; 1:5000
  • 免疫印迹; 小鼠; 1:5000
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M8159)被用于被用于免疫印迹在大鼠样本上浓度为1:5000 和 被用于免疫印迹在小鼠样本上浓度为1:5000. J Biol Chem (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 1:1000
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在人类样本上浓度为1:1000. Exp Neurol (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 小鼠; 1:500
西格玛奥德里奇 Mapk1抗体(Sigma Aldrich, M9692)被用于被用于免疫印迹在小鼠样本上浓度为1:500. PLoS ONE (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在人类样本上. Proc Natl Acad Sci U S A (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 小鼠; 1:1000; 图 4a
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4a). J Biol Chem (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫细胞化学; 人类; 图 5
西格玛奥德里奇 Mapk1抗体(Sigma, # M 8159)被用于被用于免疫细胞化学在人类样本上 (图 5). Toxicol In Vitro (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫细胞化学; 大鼠; 1:250; 图 3
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M9692)被用于被用于免疫细胞化学在大鼠样本上浓度为1:250 (图 3). J Biol Chem (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M9692)被用于被用于免疫印迹在人类样本上. Mol Biol Cell (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类
西格玛奥德里奇 Mapk1抗体(SIGMA, M8159)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • reverse phase protein lysate microarray; 人类; 1:500
西格玛奥德里奇 Mapk1抗体(Sigma, M-9692)被用于被用于reverse phase protein lysate microarray在人类样本上浓度为1:500. Pulm Pharmacol Ther (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 牛; 图 5, 6
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M8159)被用于被用于免疫印迹在牛样本上 (图 5, 6). Endocrinology (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类
西格玛奥德里奇 Mapk1抗体(Sigma, M8159)被用于被用于免疫印迹在人类样本上. Oncogene (2014) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 2d
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫印迹在人类样本上 (图 2d). Aging (Albany NY) (2020) ncbi
domestic rabbit 单克隆(E460)
  • 免疫组化; 人类; 图 8c
  • 免疫印迹; 人类; 图 6g
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab32081)被用于被用于免疫组化在人类样本上 (图 8c) 和 被用于免疫印迹在人类样本上 (图 6g). Mol Cancer (2020) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 6e, 6g
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab54230)被用于被用于免疫印迹在人类样本上 (图 6e, 6g). Aging (Albany NY) (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6e, 6g
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab214362)被用于被用于免疫印迹在人类样本上 (图 6e, 6g). Aging (Albany NY) (2020) ncbi
domestic rabbit 单克隆(EPR19401)
  • 免疫印迹; 人类; 1:1000; 图 2b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab201015)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2b). Sci Rep (2019) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 1:1000; 图 2b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab54230)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2b). Sci Rep (2019) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 小鼠; 1:500; 图 5a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab-5011)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5a). Am J Transl Res (2019) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 1:500; 图 5a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab-54230)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5a). Am J Transl Res (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 5a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab115799)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5a). Biosci Rep (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 s4
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab214362,)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s4). Cell Death Dis (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4f
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4f). Nat Commun (2019) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 1:1000; 图 4f
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4f). Nat Commun (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab115799)被用于被用于免疫印迹在人类样本上 (图 5b). Eur Rev Med Pharmacol Sci (2019) ncbi
domestic rabbit 单克隆(EPR18444)
  • 免疫印迹; 人类; 图 5b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab214036)被用于被用于免疫印迹在人类样本上 (图 5b). Eur Rev Med Pharmacol Sci (2019) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 图 7a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab54230)被用于被用于免疫印迹在小鼠样本上 (图 7a). Int J Biol Sci (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 6a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6a). Lab Invest (2019) ncbi
domestic rabbit 单克隆(EPR19401)
  • 免疫印迹; 大鼠; 1:1000; 图 5c
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab201015)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5c). Exp Ther Med (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:100; 图 5a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 5a). Exp Ther Med (2017) ncbi
domestic rabbit 单克隆(E460)
  • 免疫印迹; 人类; 1:100; 图 5b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab32081)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 5b). Exp Ther Med (2017) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 1:1000; 图 4b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab54230)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4b). Braz J Med Biol Res (2017) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 1:500; 图 3a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab54230)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 3a). J Mol Neurosci (2017) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫细胞化学; 人类; 1:200; 图 6d
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 6d). J Cell Sci (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 4a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab196883)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4a). Exp Ther Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4a). Oncotarget (2017) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, Ab50011)被用于被用于免疫印迹在大鼠样本上. PLoS ONE (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, Ab17942)被用于被用于免疫印迹在大鼠样本上. PLoS ONE (2016) ncbi
domestic rabbit 单克隆(E460)
  • 免疫组化-石蜡切片; 人类; 图 1c
  • 免疫印迹; 人类; 图 6f
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab32081)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1c) 和 被用于免疫印迹在人类样本上 (图 6f). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在人类样本上 (图 6). Sci Rep (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 6
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫印迹在人类样本上 (图 6). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 4
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在大鼠样本上 (图 4). Mol Brain (2016) ncbi
domestic rabbit 单克隆(EPR19401)
  • 免疫印迹; 大鼠; 图 4
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab201015)被用于被用于免疫印迹在大鼠样本上 (图 4). Mol Brain (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 鸡; 1:200; 图 2b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab79853)被用于被用于免疫印迹在鸡样本上浓度为1:200 (图 2b). Biometals (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 2
艾博抗(上海)贸易有限公司 Mapk1抗体(AbCam, Ab17942)被用于被用于免疫细胞化学在人类样本上 (图 2). Cancer Biol Ther (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫细胞化学; 人类; 图 2
  • 免疫印迹; 人类; 图 5
艾博抗(上海)贸易有限公司 Mapk1抗体(AbCam, Ab50011)被用于被用于免疫细胞化学在人类样本上 (图 2) 和 被用于免疫印迹在人类样本上 (图 5). Cancer Biol Ther (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2). Oncotarget (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 1d
艾博抗(上海)贸易有限公司 Mapk1抗体(abcam, 50011)被用于被用于免疫印迹在人类样本上 (图 1d). Mar Drugs (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化; 人类; 图 1
艾博抗(上海)贸易有限公司 Mapk1抗体(abcam, ab50011)被用于被用于免疫组化在人类样本上 (图 1). Mol Cancer (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 6
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫印迹在人类样本上 (图 6). Biomaterials (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 2a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫印迹在人类样本上 (图 2a). Med Oncol (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化-石蜡切片; 斑马鱼; 1:300
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫组化-石蜡切片在斑马鱼样本上浓度为1:300. J Immunol (2015) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 1:2000; 图 1d
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab54230)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 1d). J Biol Chem (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化; 大鼠; 1:200
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫组化在大鼠样本上浓度为1:200. J Surg Res (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 1:50-500
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫印迹在人类样本上浓度为1:50-500. Reprod Biol Endocrinol (2013) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化; 人类; 1:200
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫组化在人类样本上浓度为1:200. PLoS ONE (2013) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6
赛默飞世尔 Mapk1抗体(Thermo Fisher Scientific, 44-6544)被用于被用于免疫印迹在人类样本上 (图 6). Eur J Histochem (2020) ncbi
小鼠 单克隆(MILAN8R)
  • 流式细胞仪; 人类; 图 s5
赛默飞世尔 Mapk1抗体(eBioscience, MILAN8R)被用于被用于流式细胞仪在人类样本上 (图 s5). Eur J Immunol (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 4b
赛默飞世尔 Mapk1抗体(Thermo Fisher Scientific, 44-654G)被用于被用于免疫印迹在大鼠样本上 (图 4b). Biosci Rep (2018) ncbi
小鼠 单克隆(MILAN8R)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔 Mapk1抗体(eBioscience, MILAN8R)被用于被用于流式细胞仪在人类样本上 (图 3b). J Immunol (2018) ncbi
小鼠 单克隆(3F8B3)
  • 免疫印迹; 人类; 图 4
  • 免疫印迹; Stylophora pistillata; 1:1000; 图 2a
赛默飞世尔 Mapk1抗体(ThermoFisher, MA5-15605)被用于被用于免疫印迹在人类样本上 (图 4) 和 被用于免疫印迹在Stylophora pistillata样本上浓度为1:1000 (图 2a). F1000Res (2017) ncbi
domestic rabbit 单克隆(B.742.5)
  • 免疫印迹; 人类; 图 4
  • 免疫印迹; Stylophora pistillata; 1:1000; 图 2a
赛默飞世尔 Mapk1抗体(ThermoFisher, MA5-15174)被用于被用于免疫印迹在人类样本上 (图 4) 和 被用于免疫印迹在Stylophora pistillata样本上浓度为1:1000 (图 2a). F1000Res (2017) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫沉淀; 人类; 图 5a
  • 免疫印迹; 人类; 图 5a
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫沉淀在人类样本上 (图 5a) 和 被用于免疫印迹在人类样本上 (图 5a). Sci Rep (2017) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 1:500; 图 3a
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3a). Sci Rep (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1d
赛默飞世尔 Mapk1抗体(Invitrogen, 44-654G)被用于被用于免疫印迹在人类样本上 (图 1d). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1d
赛默飞世尔 Mapk1抗体(Invitrogen, 44-680G)被用于被用于免疫印迹在人类样本上 (图 1d). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 5e
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫印迹在人类样本上 (图 5e). MAbs (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3b
赛默飞世尔 Mapk1抗体(Invitrogen, 61-7400)被用于被用于免疫印迹在人类样本上 (图 3b). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; African green monkey; 图 5c
赛默飞世尔 Mapk1抗体(Zymed, 61-7400)被用于被用于免疫印迹在African green monkey样本上 (图 5c). J Biol Chem (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1b
赛默飞世尔 Mapk1抗体(Invitrogen, 44-680G)被用于被用于免疫印迹在人类样本上 (图 1b). Int J Oncol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5e
  • 免疫印迹; 人类; 图 s3b
赛默飞世尔 Mapk1抗体(生活技术, 44-680G)被用于被用于免疫印迹在小鼠样本上 (图 5e) 和 被用于免疫印迹在人类样本上 (图 s3b). Nat Immunol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s3b
  • 免疫印迹; 小鼠; 图 5e
赛默飞世尔 Mapk1抗体(生活技术, 44-654G)被用于被用于免疫印迹在人类样本上 (图 s3b) 和 被用于免疫印迹在小鼠样本上 (图 5e). Nat Immunol (2016) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 1:2000; 图 2a
赛默飞世尔 Mapk1抗体(Thermo Fisher Scientific, ERK-7D8)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 2a). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3
赛默飞世尔 Mapk1抗体(生活技术, 44-654-G)被用于被用于免疫印迹在人类样本上 (图 3). Int J Mol Sci (2016) ncbi
小鼠 单克隆(MILAN8R)
  • 流式细胞仪; 小鼠
赛默飞世尔 Mapk1抗体(eBioscience, MILAN8R)被用于被用于流式细胞仪在小鼠样本上. Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4
赛默飞世尔 Mapk1抗体(Invitrogen, 44680G)被用于被用于免疫印迹在人类样本上 (图 4). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 图 3
  • 免疫印迹; 人类; 图 1
赛默飞世尔 Mapk1抗体(Invitrogen, 44680G)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3) 和 被用于免疫印迹在人类样本上 (图 1). BMC Cancer (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6
赛默飞世尔 Mapk1抗体(Invitrogen Biosource, 44-654G)被用于被用于免疫印迹在人类样本上 (图 6). J Biol Chem (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:5000; 图 5
赛默飞世尔 Mapk1抗体(Zymed, 61-7400)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 5). Neuropharmacology (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 5
赛默飞世尔 Mapk1抗体(Invitrogen, 44-680G)被用于被用于免疫印迹在大鼠样本上 (图 5). Mol Biol Cell (2016) ncbi
domestic rabbit 多克隆
赛默飞世尔 Mapk1抗体(Invitrogen, 44680G)被用于. Int J Mol Sci (2015) ncbi
domestic rabbit 多克隆
赛默飞世尔 Mapk1抗体(Thermo Fisher Scientific, 44-680G)被用于. Biomed Res Int (2015) ncbi
domestic rabbit 多克隆
赛默飞世尔 Mapk1抗体(生活技术, 44-654-G)被用于. Oncotarget (2015) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1
赛默飞世尔 Mapk1抗体(Invitrogen, 44-680G)被用于被用于免疫印迹在人类样本上 (图 1). Oncogene (2016) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 1
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫印迹在人类样本上 (图 1). Oncogene (2016) ncbi
domestic rabbit 多克隆
赛默飞世尔 Mapk1抗体(Invitrogen, 44680G)被用于. Biochem Pharmacol (2015) ncbi
domestic rabbit 多克隆
赛默飞世尔 Mapk1抗体(生活技术, 44680G)被用于. PLoS ONE (2015) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 1:500; 图 5b
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5b). Nat Cell Biol (2015) ncbi
domestic rabbit 多克隆
赛默飞世尔 Mapk1抗体(Biosource, 44-680G)被用于. Nat Cell Biol (2015) ncbi
domestic rabbit 多克隆
赛默飞世尔 Mapk1抗体(Invitrogen, CA 61-7400)被用于. Oncotarget (2015) ncbi
domestic rabbit 多克隆
赛默飞世尔 Mapk1抗体(Invitrogen Life Technologies, 44680G)被用于. Cell Death Dis (2015) ncbi
domestic rabbit 多克隆
赛默飞世尔 Mapk1抗体(Invitrogen Life Technologies, 44-654G)被用于. Cell Death Dis (2015) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(K.913.4)
  • 免疫组化-石蜡切片; 斑马鱼
  • 免疫印迹; 斑马鱼
赛默飞世尔 Mapk1抗体(Pierce, MA5-15134)被用于被用于免疫组化-石蜡切片在斑马鱼样本上 和 被用于免疫印迹在斑马鱼样本上. Cell Res (2014) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类
赛默飞世尔 Mapk1抗体(Zymed Laboratories, 13-6200)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 1:2500; 表 1
赛默飞世尔 Mapk1抗体(Invitrogen, 136200)被用于被用于免疫印迹在大鼠样本上浓度为1:2500 (表 1). Amino Acids (2012) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2011) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 1
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫印迹在人类样本上 (图 1). J Endocrinol Invest (2011) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 图 2a
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在小鼠样本上 (图 2a). Nat Immunol (2006) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 图 6
赛默飞世尔 Mapk1抗体(Zymed, ERK-7D8)被用于被用于免疫印迹在大鼠样本上 (图 6). Cardiovasc Res (2006) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 图 7
赛默飞世尔 Mapk1抗体(Zymed, ERK-7D8)被用于被用于免疫印迹在大鼠样本上 (图 7). J Biomed Sci (2005) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 1:5000; 图 2
赛默飞世尔 Mapk1抗体(Zymed, ERK-7D8)被用于被用于免疫印迹在大鼠样本上浓度为1:5000 (图 2). Life Sci (2005) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 图 5
赛默飞世尔 Mapk1抗体(Zymed, 13-6200,)被用于被用于免疫印迹在大鼠样本上 (图 5). J Biol Chem (2004) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 2
赛默飞世尔 Mapk1抗体(Zymed Laboratories, clone ERK-7D8)被用于被用于免疫印迹在人类样本上 (图 2). J Neurochem (2000) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在大鼠样本上. J Clin Invest (1999) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 图 1, 2
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在小鼠样本上 (图 1, 2). Neurochem Res (1998) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫沉淀; 小鼠
  • 免疫印迹; 小鼠
赛默飞世尔 Mapk1抗体(Zymed, ERK-7D8)被用于被用于免疫沉淀在小鼠样本上 和 被用于免疫印迹在小鼠样本上. Proc Natl Acad Sci U S A (1998) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 非洲爪蛙; 1:1000; 图 1
赛默飞世尔 Mapk1抗体(Zymed, ERK-7D8)被用于被用于免疫印迹在非洲爪蛙样本上浓度为1:1000 (图 1). Science (1998) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 3
赛默飞世尔 Mapk1抗体(Zymed Laboratories, clone ERK-7D8)被用于被用于免疫印迹在人类样本上 (图 3). J Biol Chem (1997) ncbi
BioLegend
大鼠 单克隆(W15133B)
  • 免疫印迹; 人类; 1:1000; 图 3a
BioLegend Mapk1抗体(BioLegend, 686902)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Nat Commun (2020) ncbi
小鼠 单克隆(4B11B69)
  • 免疫印迹; 人类; 1:5000; 图 3a
BioLegend Mapk1抗体(BioLegend, 675502)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 3a). Nat Commun (2020) ncbi
小鼠 单克隆(6B8B69)
  • 流式细胞仪; 人类; 图 4c
  • 免疫印迹; 人类; 图 3d
BioLegend Mapk1抗体(BioLegend, 369506)被用于被用于流式细胞仪在人类样本上 (图 4c) 和 被用于免疫印迹在人类样本上 (图 3d). Cell (2019) ncbi
小鼠 单克隆(4B11B69)
  • 免疫印迹; 小鼠; 图 6c
BioLegend Mapk1抗体(BioLegend, 4B11B69)被用于被用于免疫印迹在小鼠样本上 (图 6c). J Clin Invest (2018) ncbi
小鼠 单克隆(4B11B69)
  • 流式细胞仪; 小鼠; 图 3b
BioLegend Mapk1抗体(Biolegend, 4B11B69)被用于被用于流式细胞仪在小鼠样本上 (图 3b). Front Immunol (2017) ncbi
亚诺法生技股份有限公司
domestic rabbit 单克隆(G15-B)
  • 免疫印迹; 人类
亚诺法生技股份有限公司 Mapk1抗体(Abnova, G15-B)被用于被用于免疫印迹在人类样本上. J Transl Med (2015) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376 S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4a). Commun Biol (2021) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000; 图 4i
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4376)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4i). Nature (2020) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 1e
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4376S)被用于被用于免疫印迹在小鼠样本上 (图 1e). Aging Cell (2020) ncbi
domestic rabbit 单克隆(D13.14.4E)
  • 免疫印迹; 人类; 1:1000; 图 8f
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST Biological Reagents Co, 8544)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8f). Int J Mol Med (2020) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:500; 图 4c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 20G11)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4c). Oncol Lett (2020) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 3d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3d). Br J Pharmacol (2020) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 6l
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 6l). PLoS Biol (2020) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上 (图 4a). Aging (Albany NY) (2020) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 5c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 197G2)被用于被用于免疫印迹在人类样本上 (图 5c). Breast Cancer Res (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 大鼠; 1:600; 图 4f
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在大鼠样本上浓度为1:600 (图 4f). Sci Signal (2019) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 7a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 7a). elife (2019) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 3f
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3f). elife (2019) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上. Nature (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 6g
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 6g). Cell Metab (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000; 图 6g
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6g). Int J Oncol (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 s3e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 s3e). J Clin Invest (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000; 图 e2b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 e2b). Nature (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 s1i
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 s1i). Cell (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:2000; 图 s2b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376S)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 s2b). Nat Commun (2019) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 7b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 7b). Cell (2019) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 1b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 1b). Cell Stem Cell (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 3d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上 (图 3d). Nature (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 大鼠; 1:2000; 图 2c
  • 免疫印迹; 大鼠; 1:1000; 图 s1b
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4376)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:2000 (图 2c) 和 被用于免疫印迹在大鼠样本上浓度为1:1000 (图 s1b). Histochem Cell Biol (2019) ncbi
  • 其他; 小鼠; 1:50; 图 3g
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 9926)被用于被用于其他在小鼠样本上浓度为1:50 (图 3g). Cell (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 6c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 6c). elife (2019) ncbi
domestic rabbit 单克隆(20G11)
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于. Nature (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:2000; 图 s4c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 9108)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 s4c). Nat Commun (2019) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 5d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上 (图 5d). Cell Rep (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 人类; 图 5a
  • 免疫印迹; 人类; 图 6c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于流式细胞仪在人类样本上 (图 5a) 和 被用于免疫印迹在人类样本上 (图 6c). J Virol (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫细胞化学; 人类; 1:1000; 图 s3c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫细胞化学在人类样本上浓度为1:1000 (图 s3c). Genes Dev (2018) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 5d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在人类样本上 (图 5d). FASEB J (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 s5j, s6h, s14f, s15g
  • 免疫组化-石蜡切片; 人类; 1:100; 图 s17b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 s5j, s6h, s14f, s15g) 和 被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 s17b). Nat Med (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:2000; 图 2a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 2a). J Neurochem (2018) ncbi
  • 免疫印迹; 小鼠; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, Inc, 9926)被用于被用于免疫印迹在小鼠样本上 (图 4a). Front Pharmacol (2018) ncbi
  • 免疫印迹; 小鼠; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, Inc, 9910s)被用于被用于免疫印迹在小鼠样本上 (图 4a). Front Pharmacol (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 小鼠; 图 9a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于流式细胞仪在小鼠样本上 (图 9a). J Exp Med (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 其他; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 8b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8b). Br J Pharmacol (2018) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 6e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6e). Nat Commun (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 小鼠; 图 1c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于流式细胞仪在小鼠样本上 (图 1c). J Clin Invest (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 3a). Brain Behav Immun (2018) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 9e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 9e). J Clin Invest (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 3d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 3d). BMC Cancer (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 3e). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 小鼠; 1:400; 图 4f
  • 免疫印迹; 人类; 1:1000; 图 s4h
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化在小鼠样本上浓度为1:400 (图 4f) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 s4h). Nature (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:3000; 图 3d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:3000 (图 3d). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4a). Breast Cancer (Dove Med Press) (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 7b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7b). Toxicol Appl Pharmacol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6b
赛信通(上海)生物试剂有限公司 Mapk1抗体(cell signalling, 9108)被用于被用于免疫印迹在人类样本上 (图 6b). elife (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在小鼠样本上 (图 3). Front Aging Neurosci (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 4a
  • 免疫印迹; 小鼠; 图 3c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于免疫印迹在人类样本上 (图 4a) 和 被用于免疫印迹在小鼠样本上 (图 3c). Sci Signal (2017) ncbi
domestic rabbit 单克隆(197G2)
  • reverse phase protein lysate microarray; 人类; 图 st6
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4377)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 st6). Cancer Cell (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1f
赛信通(上海)生物试剂有限公司 Mapk1抗体(cst, 4377S)被用于被用于免疫印迹在人类样本上 (图 1f). J Cell Sci (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 4
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4). PLoS ONE (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 5a). Am J Respir Crit Care Med (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 大鼠; 1:5000; 图 1a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在大鼠样本上浓度为1:5000 (图 1a). Cell Death Differ (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在人类样本上 (图 3a). PLoS ONE (2017) ncbi
domestic rabbit 单克隆(197G2)
  • reverse phase protein lysate microarray; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 3a). Nature (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 人类; 1:200; 图 7b
  • 免疫印迹; 人类; 1:1000; 图 7a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 7b) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 7a). Nat Commun (2017) ncbi
  • 免疫印迹; 小鼠; 1:1000; 图 6a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 9910)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6a). Behav Brain Res (2017) ncbi
  • 免疫印迹; 小鼠; 1:1000; 图 6a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 9926)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6a). Behav Brain Res (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 s5f
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 s5f). Nature (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上. Cell Syst (2017) ncbi
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 9910)被用于被用于免疫印迹在小鼠样本上. Atherosclerosis (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 6d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 9108)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6d). Sci Rep (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 12
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 12). J Neurosci Res (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 小鼠; 图 3e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化在小鼠样本上 (图 3e). PLoS ONE (2016) ncbi
  • 免疫印迹; 大鼠; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling technology, 9910)被用于被用于免疫印迹在大鼠样本上 (图 5). Oncotarget (2016) ncbi
  • 免疫印迹; 大鼠; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling technology, 9926)被用于被用于免疫印迹在大鼠样本上 (图 5). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). Cell Death Dis (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000; 图 7
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7). Respir Res (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 2d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 2d). J Exp Med (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 2a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 2a). Sci Rep (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 6h
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 6h). Nature (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 4a). Int J Mol Sci (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 7a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376S)被用于被用于免疫印迹在人类样本上 (图 7a). Cell (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:2000; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(cell signalling, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5a). Int J Mol Med (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 3g
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3g). Oncogene (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 3h
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3h). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 其他; 人类; 1:50; 图 5e
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于其他在人类样本上浓度为1:50 (图 5e) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). BMC Cancer (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 大鼠; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5a). J Physiol Biochem (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 1b). Oncotarget (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 2a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 20G11)被用于被用于免疫印迹在小鼠样本上 (图 2a). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 s6c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s6c). Nature (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 小鼠; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫组化在小鼠样本上 (图 6). elife (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 20G11)被用于被用于免疫印迹在小鼠样本上 (图 3a). J Biol Chem (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3e
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4377S)被用于被用于免疫印迹在人类样本上 (图 3e). Nature (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:2000; 图 S11
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 S11). Nat Commun (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000; 图 s4
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s4). Nat Commun (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上 (图 2). PLoS ONE (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 3a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 6). Mol Hum Reprod (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 4a). elife (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 4b
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 9108)被用于被用于免疫印迹在小鼠样本上 (图 4b) 和 被用于免疫印迹在人类样本上 (图 1b). Cell Signal (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 5c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 5c). Mucosal Immunol (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3a). Sci Rep (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4376)被用于被用于免疫印迹在人类样本上 (图 5). Oncogenesis (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Nat Commun (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 s6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 20G11)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s6). Nat Commun (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:500; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 6). Cell Death Differ (2016) ncbi
domestic rabbit 单克隆(D13.14.4E)
  • 免疫印迹; 小鼠; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 8544)被用于被用于免疫印迹在小鼠样本上 (图 5a). J Immunol (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 s2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signal, 4377S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s2). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 20G11)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Tech, 4377S)被用于被用于免疫印迹在人类样本上 (图 3). Sci Signal (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 s5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 s5). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 5e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5e). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上. Sci Rep (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 5s3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5s3). elife (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 1). PLoS ONE (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377S)被用于被用于免疫印迹在人类样本上 (图 3d). J Exp Med (2016) ncbi
domestic rabbit 单克隆(197G2)
赛信通(上海)生物试剂有限公司 Mapk1抗体(cell signalling, 4377)被用于. Mol Med Rep (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:500; 图 1b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 1b). Nat Commun (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上 (图 1). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在人类样本上 (图 5). Target Oncol (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 s7
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s7). Brain Behav (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 6b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, cs4377s)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50 (图 6b). Development (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上 (图 1). Oncogene (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 人类; 图 2
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于流式细胞仪在人类样本上 (图 2) 和 被用于免疫印迹在人类样本上 (图 2). Oncogene (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 大鼠; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5a). Int J Mol Med (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 3). elife (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 1a). Oncotarget (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 大鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Tech, 4377)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3). Nat Neurosci (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 大鼠; 1:1000; 图 8
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 8). Sci Rep (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 5c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上 (图 5c). Sci Signal (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 1:150; 图 s3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:150 (图 s3). Mol Cancer (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 s5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 20G11)被用于被用于免疫印迹在小鼠样本上 (图 s5). Nature (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376S)被用于被用于免疫印迹在小鼠样本上 (图 3). Nat Struct Mol Biol (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 大鼠; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4376S)被用于被用于免疫印迹在大鼠样本上 (图 5). J Korean Med Sci (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 2,3,4,5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376s)被用于被用于免疫印迹在小鼠样本上 (图 2,3,4,5). Cell Res (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 6a, 6b
  • 免疫印迹; 人类; 图 3a, 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 6a, 6b) 和 被用于免疫印迹在人类样本上 (图 3a, 4a). Oncotarget (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 1:500
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500. Dev Biol (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 4d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 4d). Oncotarget (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 s1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 s1). Mol Cancer Res (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 图 2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2). elife (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 7
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 7). Oncotarget (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 家羊; 1:2500
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在家羊样本上浓度为1:2500. Mol Cell Endocrinol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 1). J Immunol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4377)被用于被用于免疫印迹在人类样本上. PLoS Pathog (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5). Oncogene (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 大鼠; 1:1000; 图 4
赛信通(上海)生物试剂有限公司 Mapk1抗体(cell signalling, 4376)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4). Toxicology (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 197G2)被用于被用于免疫印迹在小鼠样本上 (图 6). Mol Biol Cell (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 犬
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 20G11)被用于被用于免疫组化-石蜡切片在犬样本上. Int J Oncol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上. Mol Cancer Ther (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 1). FASEB J (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 s3c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies,, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s3c). Nat Commun (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1500; 图 st8
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 197G2)被用于被用于免疫印迹在人类样本上浓度为1:1500 (图 st8). Gastroenterology (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 20G11)被用于被用于免疫印迹在人类样本上. Acta Neuropathol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:500; 图 4
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4). J Physiol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:500; 表 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:500 (表 3). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 s7a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4376)被用于被用于免疫印迹在小鼠样本上 (图 s7a). Nat Immunol (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling Technology, 4376)被用于被用于免疫组化-石蜡切片在人类样本上. Cancer Genet (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:2000; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 5). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 197G2)被用于被用于免疫印迹在人类样本上. J Cell Mol Med (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1a
  • 免疫印迹; 小鼠; 图 1a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在人类样本上 (图 1a) 和 被用于免疫印迹在小鼠样本上 (图 1a). Mol Carcinog (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在人类样本上. Cell Signal (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 197G2)被用于被用于免疫印迹在人类样本上 (图 2). Oncotarget (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. PLoS ONE (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 7
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7). Mol Cell Biol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 s6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s6). Development (2015) ncbi
  • 免疫印迹; 小鼠; 图 6b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 9910)被用于被用于免疫印迹在小鼠样本上 (图 6b). Cell Immunol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 8
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在小鼠样本上 (图 8). Mol Cell Biol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在人类样本上浓度为1:1000. Am J Physiol Renal Physiol (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 1:25
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:25. PLoS Genet (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 20G11)被用于被用于免疫组化在人类样本上. Cancer Cell (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 8a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377S)被用于被用于免疫印迹在小鼠样本上 (图 8a). Free Radic Biol Med (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 图 s4
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s4). Nat Commun (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上. J Mol Endocrinol (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 20G11)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376S)被用于被用于免疫组化-石蜡切片在小鼠样本上 和 被用于免疫印迹在小鼠样本上. Neoplasia (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 和 被用于免疫印迹在人类样本上浓度为1:1000. Int Immunopharmacol (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 6). PLoS ONE (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling Technology, 4377S)被用于被用于免疫印迹在人类样本上 (图 1). Cell Prolif (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; pigs ; 1:500
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在pigs 样本上浓度为1:500. Amino Acids (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在小鼠样本上. Arthritis Rheumatol (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上. Eur J Cancer (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:500
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:500. Free Radic Biol Med (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling technology, 4376)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 s1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于免疫印迹在小鼠样本上 (图 s1). Nat Immunol (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上. Cell Death Differ (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上. J Immunol (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在大鼠样本上. Brain Res (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:2500
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:2500. Brain Behav (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上. Breast Cancer Res (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在人类样本上浓度为1:1000. Int J Radiat Oncol Biol Phys (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-冰冻切片; 大鼠; 1:200
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫组化-冰冻切片在大鼠样本上浓度为1:200 和 被用于免疫印迹在大鼠样本上浓度为1:1000. BMC Complement Altern Med (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 1:75; 图 2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:75 (图 2). Genes Dev (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377S)被用于被用于免疫印迹在人类样本上. Neuro Oncol (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫组化-石蜡切片; 小鼠
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫组化-石蜡切片在小鼠样本上 和 被用于免疫印迹在小鼠样本上. J Biol Chem (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4377)被用于被用于免疫印迹在小鼠样本上. Am J Respir Cell Mol Biol (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; pigs ; 1:50
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling, 4376)被用于被用于免疫组化在pigs 样本上浓度为1:50. Dev Biol (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化在人类样本上. Mol Cancer Ther (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Nat Med (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4377)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上. PLoS ONE (2013) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 人类; 1:400
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4376)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:400 和 被用于免疫印迹在人类样本上. PLoS ONE (2013) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:200
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:200. Nat Med (2013) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4376)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上浓度为1:1000. Oncotarget (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologie, 4377)被用于被用于免疫印迹在人类样本上. Oncogenesis (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000. Head Neck (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上. Cancer Cell Int (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫组化; 小鼠
  • 免疫印迹; 小鼠; 图 2b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫组化在小鼠样本上 和 被用于免疫印迹在小鼠样本上 (图 2b). FASEB J (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫细胞化学; 小鼠; 图 4
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫细胞化学在小鼠样本上 (图 4). Stem Cells (2012) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上. J Appl Physiol (1985) (2012) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹基因敲除验证; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:1000. Development (2007) ncbi
碧迪BD
小鼠 单克隆(33/ERK2)
  • 免疫印迹; 人类; 图 s6
碧迪BD Mapk1抗体(BD Biosciences, 610103)被用于被用于免疫印迹在人类样本上 (图 s6). Sci Rep (2016) ncbi
小鼠 单克隆(33/ERK2)
  • 免疫印迹; 人类
碧迪BD Mapk1抗体(BD Biosciences, 610104)被用于被用于免疫印迹在人类样本上. Biochem Biophys Res Commun (2014) ncbi
文章列表
  1. Kitazawa K, Nadanaka S, Kadomatsu K, Kitagawa H. Chondroitin 6-sulfate represses keratinocyte proliferation in mouse skin, which is associated with psoriasis. Commun Biol. 2021;4:114 pubmed 出版商
  2. Myers D, Abram C, Wildes D, Belwafa A, Welsh A, Schulze C, et al. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Front Immunol. 2020;11:576310 pubmed 出版商
  3. Cheng C, Wooten J, Gibbs Z, McGlynn K, Mishra P, Whitehurst A. Sperm-specific COX6B2 enhances oxidative phosphorylation, proliferation, and survival in human lung adenocarcinoma. elife. 2020;9: pubmed 出版商
  4. Banik S, Pedram K, Wisnovsky S, Ahn G, Riley N, Bertozzi C. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature. 2020;584:291-297 pubmed 出版商
  5. Kim K, Gibboney S, Razy Krajka F, Lowe E, Wang W, Stolfi A. Regulation of Neurogenesis by FGF Signaling and Neurogenin in the Invertebrate Chordate Ciona. Front Cell Dev Biol. 2020;8:477 pubmed 出版商
  6. Valbuena Perez J, Linnenberger R, Dembek A, Bruscoli S, Riccardi C, Schulz M, et al. Altered glucocorticoid metabolism represents a feature of macroph-aging. Aging Cell. 2020;19:e13156 pubmed 出版商
  7. Kong Y, Xu S. Juglanin administration protects skin against UVB‑induced injury by reducing Nrf2‑dependent ROS generation. Int J Mol Med. 2020;46:67-82 pubmed 出版商
  8. Bozic M, Caus M, Rodrigues Díez R, Pedraza N, Ruiz Ortega M, Garí E, et al. Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis. Nat Commun. 2020;11:1943 pubmed 出版商
  9. Gao Q, Ouyang W, Kang B, Han X, Xiong Y, Ding R, et al. Selective targeting of the oncogenic KRAS G12S mutant allele by CRISPR/Cas9 induces efficient tumor regression. Theranostics. 2020;10:5137-5153 pubmed 出版商
  10. Inoue S, Tsunoda T, Riku M, Ito H, Inoko A, Murakami H, et al. Diffuse mesothelin expression leads to worse prognosis through enhanced cellular proliferation in colorectal cancer. Oncol Lett. 2020;19:1741-1750 pubmed 出版商
  11. Yeom J, Ma S, Lim Y. Oxyresveratrol Induces Autophagy via the ER Stress Signaling Pathway, and Oxyresveratrol-Induced Autophagy Stimulates MUC2 Synthesis in Human Goblet Cells. Antioxidants (Basel). 2020;9: pubmed 出版商
  12. Gallo S, Spilinga M, Albano R, Ferrauto G, Di Gregorio E, Casanova E, et al. Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro. Br J Pharmacol. 2020;177:3107-3122 pubmed 出版商
  13. Xu H, Du X, Xu J, Zhang Y, Tian Y, Liu G, et al. Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function. PLoS Biol. 2020;18:e3000603 pubmed 出版商
  14. Lu G, Li L, Wang B, Kuang L. LINC00623/miR-101/HRAS axis modulates IL-1β-mediated ECM degradation, apoptosis and senescence of osteoarthritis chondrocytes. Aging (Albany NY). 2020;12:3218-3237 pubmed 出版商
  15. Haag A, Walser M, Henggeler A, Hajnal A. The CHORD protein CHP-1 regulates EGF receptor trafficking and signaling in C. elegans and in human cells. elife. 2020;9: pubmed 出版商
  16. Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer. 2020;19:28 pubmed 出版商
  17. Gu Y, Zhu Z, Pei H, Xu D, Jiang Y, Zhang L, et al. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203. Aging (Albany NY). 2020;12:2333-2346 pubmed 出版商
  18. Lin L, Li Y, Liu M, Li Q, Liu Q, Li R. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation. Aging (Albany NY). 2020;12:1685-1703 pubmed 出版商
  19. Vetuschi A, Pompili S, Di Marco G, Calvaruso F, Iacomino E, Angelosante L, et al. Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps?. Eur J Histochem. 2020;64: pubmed 出版商
  20. Kennedy S, Jarboui M, Srihari S, Raso C, Bryan K, Dernayka L, et al. Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D. Nat Commun. 2020;11:499 pubmed 出版商
  21. Lee Y, Ho S, Graves J, Xiao Y, Huang S, Lin W. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer. Breast Cancer Res. 2019;21:134 pubmed 出版商
  22. Sarek G, Kotsantis P, Ruis P, Van Ly D, Margalef P, Borel V, et al. CDK phosphorylation of TRF2 controls t-loop dynamics during the cell cycle. Nature. 2019;: pubmed 出版商
  23. Jiao W, Ji J, Xu W, Bu W, Zheng Y, Ma A, et al. Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture. Sci Rep. 2019;9:15339 pubmed 出版商
  24. Wu W, Piao H, Wu F, Han Y, An D, Wu Y, et al. Yu Jin Pulvis inhibits carbon tetrachloride-induced liver fibrosis by blocking the MAPK and PI3K/Akt signaling pathways. Am J Transl Res. 2019;11:5998-6006 pubmed
  25. Veschi V, Mangiapane L, Nicotra A, Di Franco S, Scavo E, Apuzzo T, et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene. 2020;39:987-1003 pubmed 出版商
  26. Zhang L, Zheng C, Sun Z, Wang H, Wang F. Long non-coding RNA urothelial cancer associated 1 can regulate the migration and invasion of colorectal cancer cells (SW480) via myocardin-related transcription factor-A. Oncol Lett. 2019;18:4185-4193 pubmed 出版商
  27. Gomes A, Ilter D, Low V, Rosenzweig A, Shen Z, Schild T, et al. Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization. Cancer Cell. 2019;36:402-417.e13 pubmed 出版商
  28. Wang H, Wei Y, Pu Y, Jiang D, Jiang X, Zhang Y, et al. Brain-derived neurotrophic factor stimulation of T-type Ca2+ channels in sensory neurons contributes to increased peripheral pain sensitivity. Sci Signal. 2019;12: pubmed 出版商
  29. Wang Q, Yang Q, Zhang A, Kang Z, Wang Y, Zhang Z. Silencing of SPARC represses heterotopic ossification via inhibition of the MAPK signaling pathway. Biosci Rep. 2019;39: pubmed 出版商
  30. Zhong B, Shi D, Wu F, Wang S, Hu H, Cheng C, et al. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma. Cell Death Dis. 2019;10:687 pubmed 出版商
  31. Deng Q, Li P, Che M, Liu J, Biswas S, Ma G, et al. Activation of hedgehog signaling in mesenchymal stem cells induces cartilage and bone tumor formation via Wnt/β-Catenin. elife. 2019;8: pubmed 出版商
  32. Park M, Kim A, Manandhar S, Oh S, Jang G, Kang L, et al. CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity. elife. 2019;8: pubmed 出版商
  33. Sang D, Pinglay S, Wiewiora R, Selvan M, Lou H, Chodera J, et al. Ancestral reconstruction reveals mechanisms of ERK regulatory evolution. elife. 2019;8: pubmed 出版商
  34. Debruyne D, Dries R, Sengupta S, Seruggia D, Gao Y, Sharma B, et al. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells. Nature. 2019;572:676-680 pubmed 出版商
  35. Birtley J, Alomary M, Zanini E, Antony J, Maben Z, Weaver G, et al. Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions. Nat Commun. 2019;10:3134 pubmed 出版商
  36. Bi J, Ichu T, Zanca C, Yang H, Zhang W, Gu Y, et al. Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling. Cell Metab. 2019;30:525-538.e8 pubmed 出版商
  37. Suo L, Chang X, Xu N, Ji H. The Anti-proliferative Activity of GnRH Through Downregulation of the Akt/ERK Pathways in Pancreatic Cancer. Front Endocrinol (Lausanne). 2019;10:370 pubmed 出版商
  38. Wang L, Shi H, Liu Y, Zhang W, Duan X, Li M, et al. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway. Int J Oncol. 2019;55:473-487 pubmed 出版商
  39. Ligorio M, Sil S, Malagon Lopez J, Nieman L, Misale S, Di Pilato M, et al. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer. Cell. 2019;: pubmed 出版商
  40. Pan C, Jin L, Wang X, Li Y, Chun J, Boese A, et al. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. J Clin Invest. 2019;129:2431-2445 pubmed 出版商
  41. Zhao J, Sun H, Zhang J, Wang M, Du X, Zhang J. Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma. Eur Rev Med Pharmacol Sci. 2019;23:3173-3182 pubmed 出版商
  42. Jia Y, Li H, Wang J, Wang Y, Zhang P, Ma N, et al. Phosphorylation of 14-3-3ζ links YAP transcriptional activation to hypoxic glycolysis for tumorigenesis. Oncogenesis. 2019;8:31 pubmed 出版商
  43. Chung H, Zou X, Bajar B, Brand V, Huo Y, Alcudia J, et al. A compact synthetic pathway rewires cancer signaling to therapeutic effector release. Science. 2019;364: pubmed 出版商
  44. Xu D, Li X, Shao F, Lv G, Lv H, Lee J, et al. The protein kinase activity of fructokinase A specifies the antioxidant responses of tumor cells by phosphorylating p62. Sci Adv. 2019;5:eaav4570 pubmed 出版商
  45. Shi Y, Gao W, Lytle N, Huang P, Yuan X, Dann A, et al. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. 2019;569:131-135 pubmed 出版商
  46. Nakanishi M, Mitchell R, Benoit Y, Orlando L, Reid J, Shimada K, et al. Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells. Cell. 2019;177:910-924.e22 pubmed 出版商
  47. Gao L, Hu Y, Tian Y, Fan Z, Wang K, Li H, et al. Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition. Nat Commun. 2019;10:1665 pubmed 出版商
  48. Hancock M, Meyer R, Mistry M, Khetani R, Wagschal A, Shin T, et al. Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression. Cell. 2019;177:722-736.e22 pubmed 出版商
  49. Wang E, Dai Z, Ferrante A, Drake C, Christiano A. A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth. Cell Stem Cell. 2019;: pubmed 出版商
  50. Yao W, Rose J, Wang W, Seth S, Jiang H, Taguchi A, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019;: pubmed 出版商
  51. Mammone T, Chidlow G, Casson R, Wood J. Improved immunohistochemical detection of phosphorylated mitogen-activated protein kinases in the injured rat optic nerve head. Histochem Cell Biol. 2019;151:435-456 pubmed 出版商
  52. Joy M, Ben Assayag E, Shabashov Stone D, Liraz Zaltsman S, Mazzitelli J, Arenas M, et al. CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury. Cell. 2019;176:1143-1157.e13 pubmed 出版商
  53. Yambire K, Fernández Mosquera L, Steinfeld R, Mühle C, Ikonen E, Milosevic I, et al. Mitochondrial biogenesis is transcriptionally repressed in lysosomal lipid storage diseases. elife. 2019;8: pubmed 出版商
  54. Li J, Liu X, Chen H, Sun Z, Chen H, Wang L, et al. Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis. BMC Complement Altern Med. 2019;19:48 pubmed 出版商
  55. Liu J, Zhu G, Jia N, Wang W, Wang Y, Yin M, et al. CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17. Int J Biol Sci. 2019;15:493-506 pubmed 出版商
  56. Dai L, Hu W, Yang Z, Chen D, He B, Chen Y, et al. Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis. Lab Invest. 2019;99:736-748 pubmed 出版商
  57. Jeong W, Park J, Kim W, Ro E, Jeon S, Lee S, et al. WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. Nat Commun. 2019;10:295 pubmed 出版商
  58. Nerurkar N, Lee C, Mahadevan L, Tabin C. Molecular control of macroscopic forces drives formation of the vertebrate hindgut. Nature. 2019;565:480-484 pubmed 出版商
  59. Smith B, Wang S, Jaime Figueroa S, Harbin A, Wang J, Hamman B, et al. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase. Nat Commun. 2019;10:131 pubmed 出版商
  60. Laurenzana A, Margheri F, Biagioni A, Chillà A, Pimpinelli N, Ruzzolini J, et al. EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells. EBioMedicine. 2019;39:194-206 pubmed 出版商
  61. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed 出版商
  62. Zhao H, Martin E, Matalkah F, Shah N, Ivanov A, Ruppert J, et al. Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis. Oncogene. 2019;38:2275-2290 pubmed 出版商
  63. Lee S, Cho Y, Cha P, Yoon J, Ro E, Jeong W, et al. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab. Exp Mol Med. 2018;50:153 pubmed 出版商
  64. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed 出版商
  65. Fossati G, Pozzi D, Canzi A, Mirabella F, Valentino S, Morini R, et al. Pentraxin 3 regulates synaptic function by inducing AMPA receptor clustering via ECM remodeling and β1-integrin. EMBO J. 2019;38: pubmed 出版商
  66. Xu P, Chen A, Ganaie S, Cheng F, Shen W, Wang X, et al. The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs. J Virol. 2019;93: pubmed 出版商
  67. McCloskey A, Ibarra A, Hetzer M. Tpr regulates the total number of nuclear pore complexes per cell nucleus. Genes Dev. 2018;32:1321-1331 pubmed 出版商
  68. Chen S, Yun F, Yao Y, Cao M, Zhang Y, Wang J, et al. USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein. J Exp Med. 2018;215:2850-2867 pubmed 出版商
  69. Imbrechts M, De Samblancx K, Fierens K, Brisse E, Vandenhaute J, Mitera T, et al. IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways. Eur J Immunol. 2018;48:1506-1521 pubmed 出版商
  70. Xiao N, Li H, Yu W, Gu C, Fang H, Peng Y, et al. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation. FASEB J. 2019;33:163-174 pubmed 出版商
  71. Weiss J, Davies L, Karwan M, Ileva L, Ozaki M, Cheng R, et al. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors. J Clin Invest. 2018;128:3794-3805 pubmed 出版商
  72. Li F, Li Y, Liang H, Xu T, Kong Y, Huang M, et al. HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection. J Clin Invest. 2018;128:4148-4162 pubmed 出版商
  73. Li R, Sahu S, Schachner M. Phenelzine, a small organic compound mimicking the functions of cell adhesion molecule L1, promotes functional recovery after mouse spinal cord injury. Restor Neurol Neurosci. 2018;36:469-483 pubmed 出版商
  74. Lei F, Jin L, Liu X, Lai F, Yan X, Farrelly M, et al. RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors. Cell Death Dis. 2018;9:679 pubmed 出版商
  75. Ruess D, Heynen G, Ciecielski K, Ai J, Berninger A, Kabacaoglu D, et al. Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. Nat Med. 2018;24:954-960 pubmed 出版商
  76. Lautz J, Brown E, Williams VanSchoiack A, Smith S. Synaptic activity induces input-specific rearrangements in a targeted synaptic protein interaction network. J Neurochem. 2018;146:540-559 pubmed 出版商
  77. Xue Z, Vis D, Bruna A, Sustic T, van Wageningen S, Batra A, et al. MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models. Cell Res. 2018;28:719-729 pubmed 出版商
  78. Huang M, Qi W, Fang S, Jiang P, Yang C, Mo Y, et al. Pigment Epithelium-Derived Factor Plays a Role in Alzheimer's Disease by Negatively Regulating Aβ42. Neurotherapeutics. 2018;15:728-741 pubmed 出版商
  79. Yu Y, Shen Q, Lai Y, Park S, Ou X, Lin D, et al. Anti-inflammatory Effects of Curcumin in Microglial Cells. Front Pharmacol. 2018;9:386 pubmed 出版商
  80. Ahmad F, Salahuddin M, Alsamman K, Herzallah H, Al Otaibi S. Neonatal maternal deprivation impairs localized de novo activity-induced protein translation at the synapse in the rat hippocampus. Biosci Rep. 2018;38: pubmed 出版商
  81. Durai V, Bagadia P, Briseño C, Theisen D, Iwata A, Davidson J, et al. Altered compensatory cytokine signaling underlies the discrepancy between Flt3-/- and Flt3l-/- mice. J Exp Med. 2018;215:1417-1435 pubmed 出版商
  82. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  83. Lino Cardenas C, Kessinger C, Cheng Y, MacDonald C, Macgillivray T, Ghoshhajra B, et al. An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat Commun. 2018;9:1009 pubmed 出版商
  84. Qi Z, Xu H, Zhang S, Xu J, Li S, Gao H, et al. RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling. Int J Oncol. 2018;52:1105-1116 pubmed 出版商
  85. Lu Y, Kim N, Jiang Y, Zhang H, Zheng D, Zhu F, et al. Cambogin suppresses dextran sulphate sodium-induced colitis by enhancing Treg cell stability and function. Br J Pharmacol. 2018;175:1085-1099 pubmed 出版商
  86. De Pasquale V, Pezone A, Sarogni P, Tramontano A, Schiattarella G, Avvedimento V, et al. EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB. Cell Death Dis. 2018;9:40 pubmed 出版商
  87. Velázquez Villegas L, Perino A, Lemos V, Zietak M, Nomura M, Pols T, et al. TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue. Nat Commun. 2018;9:245 pubmed 出版商
  88. Qian Z, Ryu B, Kang K, Heo S, Kang D, Bae S, et al. Cellular properties of the fermented microalgae Pavlova lutheri and its isolated active peptide in osteoblastic differentiation of MG?63 cells. Mol Med Rep. 2018;17:2044-2050 pubmed 出版商
  89. Cho M, Lee J, Shin M, Kim H, Choi Y, Rho S, et al. TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer. Oncotarget. 2017;8:97990-98003 pubmed 出版商
  90. Wang C, Edilova M, Wagar L, Mujib S, Singer M, Bernard N, et al. Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy. J Immunol. 2018;200:558-564 pubmed 出版商
  91. Muro R, Nitta T, Nakano K, Okamura T, Takayanagi H, Suzuki H. γδTCR recruits the Syk/PI3K axis to drive proinflammatory differentiation program. J Clin Invest. 2018;128:415-426 pubmed 出版商
  92. Balan I, Warnock K, Puche A, GONDRE LEWIS M, Aurelian L. Innately activated TLR4 signal in the nucleus accumbens is sustained by CRF amplification loop and regulates impulsivity. Brain Behav Immun. 2018;69:139-153 pubmed 出版商
  93. Bostner J, Alayev A, Berman A, Fornander T, Nordenskjold B, Holz M, et al. Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2018;168:17-27 pubmed 出版商
  94. Liang Z, Yang Y, He Y, Yang P, Wang X, He G, et al. SUMOylation of IQGAP1 promotes the development of colorectal cancer. Cancer Lett. 2017;411:90-99 pubmed 出版商
  95. Tsutsumi R, Harizanova J, Stockert R, Schröder K, Bastiaens P, Neel B. Assay to visualize specific protein oxidation reveals spatio-temporal regulation of SHP2. Nat Commun. 2017;8:466 pubmed 出版商
  96. Zhao F, Franco H, Rodriguez K, Brown P, Tsai M, Tsai S, et al. Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice. Science. 2017;357:717-720 pubmed 出版商
  97. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed 出版商
  98. Quadri H, Aiken T, Allgaeuer M, Moravec R, Altekruse S, Hussain S, et al. Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer. BMC Cancer. 2017;17:495 pubmed 出版商
  99. Courtial L, Picco V, Pagès G, Ferrier Pagès C. Validation of commercial ERK antibodies against the ERK orthologue of the scleractinian coral Stylophora pistillata. F1000Res. 2017;6:577 pubmed 出版商
  100. Olivares O, Mayers J, Gouirand V, Torrence M, Gicquel T, Borge L, et al. Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat Commun. 2017;8:16031 pubmed 出版商
  101. Zhang C, Mao H, Cao Y. Nuclear accumulation of symplekin promotes cellular proliferation and dedifferentiation in an ERK1/2-dependent manner. Sci Rep. 2017;7:3769 pubmed 出版商
  102. Wang R, Cao X, Kulej K, Liu W, Ma T, MacDonald M, et al. Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma. Proc Natl Acad Sci U S A. 2017;114:E5352-E5361 pubmed 出版商
  103. Kamerkar S, LeBleu V, Sugimoto H, Yang S, Ruivo C, Melo S, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498-503 pubmed 出版商
  104. Szoka L, Karna E, Hlebowicz Sarat K, Karaszewski J, Palka J. Exogenous proline stimulates type I collagen and HIF-1? expression and the process is attenuated by glutamine in human skin fibroblasts. Mol Cell Biochem. 2017;435:197-206 pubmed 出版商
  105. Nishimura S, Mishra Gorur K, Park J, Surovtseva Y, Sebti S, Levchenko A, et al. Combined HMG-COA reductase and prenylation inhibition in treatment of CCM. Proc Natl Acad Sci U S A. 2017;114:5503-5508 pubmed 出版商
  106. Ma S, Wan X, Deng Z, Shi L, Hao C, Zhou Z, et al. Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs. J Exp Med. 2017;214:1471-1491 pubmed 出版商
  107. Chen M, Dai L, Fei A, Pan S, Wang H. Isoquercetin activates the ERK1/2-Nrf2 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro. Exp Ther Med. 2017;13:1353-1359 pubmed 出版商
  108. He L, Zhang L, Wang M, Wang W. miR-9 functions as a tumor inhibitor of cell proliferation in epithelial ovarian cancer through targeting the SDF-1/CXCR4 pathway. Exp Ther Med. 2017;13:1203-1208 pubmed 出版商
  109. Yang X, Qi L, Lin F, Ou Z. The role of the chemokine receptor XCR1 in breast cancer cells. Breast Cancer (Dove Med Press). 2017;9:227-236 pubmed 出版商
  110. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed 出版商
  111. Yan X, Zhu Z, Xu S, Yang L, Liao X, Zheng M, et al. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways. Sci Rep. 2017;7:45915 pubmed 出版商
  112. Bai X, Hong W, Cai P, Chen Y, Xu C, Cao D, et al. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicol Appl Pharmacol. 2017;324:12-25 pubmed 出版商
  113. Mon N, Senga T, Ito S. Interleukin-1? activates focal adhesion kinase and Src to induce matrix metalloproteinase-9 production and invasion of MCF-7 breast cancer cells. Oncol Lett. 2017;13:955-960 pubmed 出版商
  114. Schweighoffer E, Nys J, Vanes L, Smithers N, Tybulewicz V. TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK. J Exp Med. 2017;214:1269-1280 pubmed 出版商
  115. Fischer A, Harrison K, Ramirez Y, Auer D, Chowdhury S, Prusty B, et al. Chlamydia trachomatis-containing vacuole serves as deubiquitination platform to stabilize Mcl-1 and to interfere with host defense. elife. 2017;6: pubmed 出版商
  116. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed 出版商
  117. Yang K, Chen Y, To K, Wang F, Li D, Chen L, et al. Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo. Exp Mol Med. 2017;49:e303 pubmed 出版商
  118. Balmer D, Bapst Wicht L, Pyakurel A, Emery M, Nanchen N, Bochet C, et al. Bis-Retinoid A2E Induces an Increase of Basic Fibroblast Growth Factor via Inhibition of Extracellular Signal-Regulated Kinases 1/2 Pathway in Retinal Pigment Epithelium Cells and Facilitates Phagocytosis. Front Aging Neurosci. 2017;9:43 pubmed 出版商
  119. CAROMILE L, Dortche K, Rahman M, Grant C, Stoddard C, Ferrer F, et al. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer. Sci Signal. 2017;10: pubmed 出版商
  120. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed 出版商
  121. Li L, Baxter S, Gu N, Ji M, Zhan X. Missing-in-metastasis protein downregulates CXCR4 by promoting ubiquitylation and interaction with small Rab GTPases. J Cell Sci. 2017;130:1475-1485 pubmed 出版商
  122. Chung C, Chang C, Hsu C, Lin K, Peng H, Huang T. Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1. Sci Rep. 2017;7:43612 pubmed 出版商
  123. de Oliveira R, de Campos Castilho G, da Cunha A, Miyajima F, de Oliveira Martins D. Dilodendron bipinnatum Radlk. inhibits pro-inflammatory mediators through the induction of MKP-1 and the down-regulation of MAPKp38/JNK/NF-?B pathways and COX-2 in LPS-activated RAW 264.7 cells. J Ethnopharmacol. 2017;202:127-137 pubmed 出版商
  124. Pan X, Wang Y, Lübke T, Hinek A, Pshezhetsky A. Mice, double deficient in lysosomal serine carboxypeptidases Scpep1 and Cathepsin A develop the hyperproliferative vesicular corneal dystrophy and hypertrophic skin thickenings. PLoS ONE. 2017;12:e0172854 pubmed 出版商
  125. Wang H, Shan X, Qiao Y. PDK2 promotes chondrogenic differentiation of mesenchymal stem cells by upregulation of Sox6 and activation of JNK/MAPK/ERK pathway. Braz J Med Biol Res. 2017;50:e5988 pubmed 出版商
  126. Radder J, Zhang Y, Gregory A, Yu S, Kelly N, Leader J, et al. Extreme Trait Whole-Genome Sequencing Identifies PTPRO as a Novel Candidate Gene in Emphysema with Severe Airflow Obstruction. Am J Respir Crit Care Med. 2017;196:159-171 pubmed 出版商
  127. Tao C, Hsu W, Ma Y, Cheng S, Lee E. Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against Aβ toxicity in a mouse model of Alzheimer's disease. Cell Death Differ. 2017;24:597-614 pubmed 出版商
  128. Ni Y, Teng T, Li R, Simonyi A, Sun G, Lee J. TNFα alters occludin and cerebral endothelial permeability: Role of p38MAPK. PLoS ONE. 2017;12:e0170346 pubmed 出版商
  129. Carpi S, Fogli S, Polini B, Montagnani V, Podestà A, Breschi M, et al. Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. Toxicol In Vitro. 2017;40:272-279 pubmed 出版商
  130. Difranco K, Mulligan J, Sumal A, Diamond G. Induction of CFTR gene expression by 1,25(OH)2 vitamin D3, 25OH vitamin D3, and vitamin D3 in cultured human airway epithelial cells and in mouse airways. J Steroid Biochem Mol Biol. 2017;173:323-332 pubmed 出版商
  131. Li M, Yuan Y, Hu B, Wu L. Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease. J Mol Neurosci. 2017;61:489-497 pubmed 出版商
  132. Lisse T, Rieger S. IKKα regulates human keratinocyte migration through surveillance of the redox environment. J Cell Sci. 2017;130:975-988 pubmed 出版商
  133. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed 出版商
  134. Schober T, Magg T, Laschinger M, Rohlfs M, Linhares N, Puchalka J, et al. A human immunodeficiency syndrome caused by mutations in CARMIL2. Nat Commun. 2017;8:14209 pubmed 出版商
  135. Feng L, Xue D, Chen E, Zhang W, Gao X, Yu J, et al. HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Exp Ther Med. 2016;12:3941-3947 pubmed 出版商
  136. Peng Y, Shi X, Li Z, He X, Sun Y. Particularly interesting Cys-His-rich protein is highly expressed in human intracranial aneurysms and resists aneurysmal rupture. Exp Ther Med. 2016;12:3905-3912 pubmed 出版商
  137. Asensio Juan E, Fueyo R, PAPPA S, Iacobucci S, Badosa C, Lois S, et al. The histone demethylase PHF8 is a molecular safeguard of the IFNγ response. Nucleic Acids Res. 2017;45:3800-3811 pubmed 出版商
  138. Xu X, Fan Z, Liang C, Li L, Wang L, Liang Y, et al. A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity. Nat Commun. 2017;8:14059 pubmed 出版商
  139. Su W, Zhang Y, Chen Y, Gong H, Lian Y, Peng W, et al. NLRP3 gene knockout blocks NF-?B and MAPK signaling pathway in CUMS-induced depression mouse model. Behav Brain Res. 2017;322:1-8 pubmed 出版商
  140. Kozlovskaja GumbrienÄ— A, Yi R, Alexander R, Aman A, Jiskra R, Nagelberg D, et al. Proliferation-independent regulation of organ size by Fgf/Notch signaling. elife. 2017;6: pubmed 出版商
  141. Kidger A, Rushworth L, Stellzig J, Davidson J, Bryant C, Bayley C, et al. Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling. Proc Natl Acad Sci U S A. 2017;114:E317-E326 pubmed 出版商
  142. Babagana M, Johnson S, Slabodkin H, Bshara W, Morrison C, Kandel E. P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells. Mol Carcinog. 2017;56:1515-1525 pubmed 出版商
  143. Matsumoto A, Pasut A, Matsumoto M, Yamashita R, Fung J, Monteleone E, et al. mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature. 2017;541:228-232 pubmed 出版商
  144. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed 出版商
  145. Baumer Y, McCurdy S, Alcala M, Mehta N, Lee B, Ginsberg M, et al. CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis. Atherosclerosis. 2017;256:105-114 pubmed 出版商
  146. Takahashi M, Li Y, Dillon T, Stork P. Phosphorylation of Rap1 by cAMP-dependent Protein Kinase (PKA) Creates a Binding Site for KSR to Sustain ERK Activation by cAMP. J Biol Chem. 2017;292:1449-1461 pubmed 出版商
  147. Fourneaux B, Chaire V, Lucchesi C, Karanian M, Pineau R, Laroche Clary A, et al. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications. Oncotarget. 2017;8:7878-7890 pubmed 出版商
  148. Wang S, Cheng Y, Zheng Y, He Z, Chen W, Zhou W, et al. PRKAR1A is a functional tumor suppressor inhibiting ERK/Snail/E-cadherin pathway in lung adenocarcinoma. Sci Rep. 2016;6:39630 pubmed 出版商
  149. Lopes M, Leal R, Guarnieri R, Schwarzbold M, Hoeller A, Diaz A, et al. A single high dose of dexamethasone affects the phosphorylation state of glutamate AMPA receptors in the human limbic system. Transl Psychiatry. 2016;6:e986 pubmed 出版商
  150. Jung J, Jung H, Neupane S, Kim K, Kim J, Yamamoto H, et al. Involvement of PI3K and PKA pathways in mouse tongue epithelial differentiation. Acta Histochem. 2017;119:92-98 pubmed 出版商
  151. Nagahara Y, Shimazawa M, Ohuchi K, Ito J, Takahashi H, Tsuruma K, et al. GPNMB ameliorates mutant TDP-43-induced motor neuron cell death. J Neurosci Res. 2017;95:1647-1665 pubmed 出版商
  152. Weyandt J, Carney J, Pavlisko E, Xu M, Counter C. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice. PLoS ONE. 2016;11:e0167205 pubmed 出版商
  153. Bangi E, Murgia C, Teague A, Sansom O, Cagan R. Functional exploration of colorectal cancer genomes using Drosophila. Nat Commun. 2016;7:13615 pubmed 出版商
  154. Roversi F, Pericole F, Machado Neto J, da Silva Santos Duarte A, Longhini A, Corrocher F, et al. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway. Biochim Biophys Acta Mol Basis Dis. 2017;1863:450-461 pubmed 出版商
  155. Feng W, Zhang K, Liu Y, Chen J, Cai Q, Zhang Y, et al. Apocynin attenuates angiotensin II-induced vascular smooth muscle cells osteogenic switching via suppressing extracellular signal-regulated kinase 1/2. Oncotarget. 2016;7:83588-83600 pubmed 出版商
  156. Wang Y, Chiang H, Huang Y, Hsu C, Yang P, Juan H, et al. A link between adipogenesis and innate immunity: RNase-L promotes 3T3-L1 adipogenesis by destabilizing Pref-1 mRNA. Cell Death Dis. 2016;7:e2458 pubmed 出版商
  157. Milara J, Cervera A, de Diego A, Sanz C, Juan G, Gavaldá A, et al. Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients. Respir Res. 2016;17:145 pubmed
  158. Hegedüs L, Garay T, Molnar E, Varga K, Bilecz A, Torok S, et al. The plasma membrane Ca2+ pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells. Int J Cancer. 2017;140:2758-2770 pubmed 出版商
  159. Hu Y, Kim J, He K, Wan Q, Kim J, Flach M, et al. Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion. J Exp Med. 2016;213:2759-2772 pubmed
  160. Alekhina O, Marchese A. ?-Arrestin1 and Signal-transducing Adaptor Molecule 1 (STAM1) Cooperate to Promote Focal Adhesion Kinase Autophosphorylation and Chemotaxis via the Chemokine Receptor CXCR4. J Biol Chem. 2016;291:26083-26097 pubmed
  161. Grugan K, Dorn K, Jarantow S, Bushey B, Pardinas J, Laquerre S, et al. Fc-mediated activity of EGFR x c-Met bispecific antibody JNJ-61186372 enhanced killing of lung cancer cells. MAbs. 2017;9:114-126 pubmed 出版商
  162. Ismail H, Didangelos A, Vincent T, Saklatvala J. Rapid Activation of Transforming Growth Factor ?-Activated Kinase 1 in Chondrocytes by Phosphorylation and K63 -Linked Polyubiquitination Upon Injury to Animal Articular Cartilage. Arthritis Rheumatol. 2017;69:565-575 pubmed 出版商
  163. Che D, Zhou T, Lan Y, Xie J, Gong H, Li C, et al. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells. Int J Mol Med. 2016;38:1815-1822 pubmed 出版商
  164. Li S, Yang B, Teguh D, Zhou L, Xu J, Rong L. Amyloid ? Peptide Enhances RANKL-Induced Osteoclast Activation through NF-?B, ERK, and Calcium Oscillation Signaling. Int J Mol Sci. 2016;17: pubmed
  165. Yue G, Xie S, Lee J, Kwok H, Gao S, Nian Y, et al. New potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatment. Sci Rep. 2016;6:35263 pubmed 出版商
  166. Rodina A, Wang T, Yan P, Gomes E, Dunphy M, Pillarsetty N, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. 2016;538:397-401 pubmed 出版商
  167. Yong K, Li A, Ou W, Hong C, Zhao W, Wang F, et al. Targeting SALL4 by entinostat in lung cancer. Oncotarget. 2016;7:75425-75440 pubmed 出版商
  168. Belliard A, Gulati G, Duan Q, Alves R, Brewer S, Madan N, et al. Ischemia/reperfusion-induced alterations of enzymatic and signaling functions of the rat cardiac Na+/K+-ATPase: protection by ouabain preconditioning. Physiol Rep. 2016;4: pubmed
  169. Zhong W, Wang X, Pan B, Li F, Kuang L, Su Z. Eupatilin induces human renal cancer cell apoptosis via ROS-mediated MAPK and PI3K/AKT signaling pathways. Oncol Lett. 2016;12:2894-2899 pubmed
  170. Lu W, Shi J, Zhang J, Lv Z, Guo F, Huang H, et al. CXCL12/CXCR4 Axis Regulates Aggrecanase Activation and Cartilage Degradation in a Post-Traumatic Osteoarthritis Rat Model. Int J Mol Sci. 2016;17: pubmed
  171. Jin Q, Ren Y, Wang M, Suraneni P, Li D, Crispino J, et al. Novel function of FAXDC2 in megakaryopoiesis. Blood Cancer J. 2016;6:e478 pubmed 出版商
  172. Chen B, Zeng X, He Y, Wang X, Liang Z, Liu J, et al. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget. 2016;7:71400-71416 pubmed 出版商
  173. Xin H, ZHONG C, Nudleman E, Ferrara N. Evidence for Pro-angiogenic Functions of VEGF-Ax. Cell. 2016;167:275-284.e6 pubmed 出版商
  174. Jansson D, Scotter E, Rustenhoven J, Coppieters N, Smyth L, Oldfield R, et al. Interferon-? blocks signalling through PDGFR? in human brain pericytes. J Neuroinflammation. 2016;13:249 pubmed
  175. Egholm C, Khammy M, Dalsgaard T, Mazur A, Tritsaris K, Hansen A, et al. GLP-1 inhibits VEGFA-mediated signaling in isolated human endothelial cells and VEGFA-induced dilation of rat mesenteric arteries. Am J Physiol Heart Circ Physiol. 2016;311:H1214-H1224 pubmed 出版商
  176. Torres A, Vargas Y, Uribe D, Jaramillo C, Gleisner A, Salazar Onfray F, et al. Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells. Oncotarget. 2016;7:67373-67386 pubmed 出版商
  177. Zhong Y, Zou L, Wang Z, Pan Y, Dai Z, Liu X, et al. Lrrc75b is a novel negative regulator of C2C12 myogenic differentiation. Int J Mol Med. 2016;38:1411-1418 pubmed 出版商
  178. Yadav V, Hong K, Zeldin D, Nayeem M. Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A1 receptor-dependent contraction in mouse mesenteric arteries: role of ATP-sensitive K+ channels. Mol Cell Biochem. 2016;422:197-206 pubmed
  179. Gross S, Devraj K, Feng Y, Macas J, Liebner S, Wieland T. Nucleoside diphosphate kinase B regulates angiogenic responses in the endothelium via caveolae formation and c-Src-mediated caveolin-1 phosphorylation. J Cereb Blood Flow Metab. 2017;37:2471-2484 pubmed 出版商
  180. Wu Y, Ren D, Chen G. Siglec-E Negatively Regulates the Activation of TLR4 by Controlling Its Endocytosis. J Immunol. 2016;197:3336-3347 pubmed
  181. Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene. 2017;36:1573-1584 pubmed 出版商
  182. Wang H, Han X, Bretz C, Becker S, Gambhir D, Smith G, et al. Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization. Mol Ther Methods Clin Dev. 2016;3:16056 pubmed 出版商
  183. García Carpizo V, Sarmentero J, Han B, Grana O, Ruiz Llorente S, Pisano D, et al. NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation. Sci Rep. 2016;6:32952 pubmed 出版商
  184. Makita N, Sato T, Yajima Shoji Y, Sato J, Manaka K, Eda Hashimoto M, et al. Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist. J Biol Chem. 2016;291:22460-22471 pubmed
  185. Caporali S, Alvino E, Lacal P, Levati L, Giurato G, Memoli D, et al. Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor. Int J Oncol. 2016;49:1164-74 pubmed 出版商
  186. Nettersheim D, Jostes S, Fabry M, Honecker F, Schumacher V, Kirfel J, et al. A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment. Oncotarget. 2016;7:74931-74946 pubmed 出版商
  187. Shang W, Zhao L, Dong X, Zhao Z, Li J, Zhang B, et al. Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways. Mol Med Rep. 2016;14:3620-6 pubmed 出版商
  188. Padhan N, Nordling T, Sundstrom M, Akerud P, Birgisson H, Nygren P, et al. High sensitivity isoelectric focusing to establish a signaling biomarker for the diagnosis of human colorectal cancer. BMC Cancer. 2016;16:683 pubmed 出版商
  189. Kupka S, De Miguel D, Dráber P, Martino L, Surinova S, Rittinger K, et al. SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. Cell Rep. 2016;16:2271-80 pubmed 出版商
  190. Greenwood E, Maisel S, Ebertz D, Russ A, Pandey R, SCHROEDER J. Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration. Oncotarget. 2016;7:60776-60792 pubmed 出版商
  191. Nehra S, Bhardwaj V, Bansal A, Saraswat D. Nanocurcumin accords protection against acute hypobaric hypoxia induced lung injury in rats. J Physiol Biochem. 2016;72:763-779 pubmed
  192. Li Y, Dillon T, Takahashi M, Earley K, Stork P. Protein Kinase A-independent Ras Protein Activation Cooperates with Rap1 Protein to Mediate Activation of the Extracellular Signal-regulated Kinases (ERK) by cAMP. J Biol Chem. 2016;291:21584-21595 pubmed
  193. Ruess D, Probst M, Marjanovic G, Wittel U, Hopt U, Keck T, et al. HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury. PLoS ONE. 2016;11:e0161233 pubmed 出版商
  194. Stucky A, Bakshi K, Friedman E, Wang H. Prenatal Cocaine Exposure Upregulates BDNF-TrkB Signaling. PLoS ONE. 2016;11:e0160585 pubmed 出版商
  195. Tadjuidje E, Kofron M, Mir A, Wylie C, Heasman J, Cha S. Nodal signalling in Xenopus: the role of Xnr5 in left/right asymmetry and heart development. Open Biol. 2016;6: pubmed 出版商
  196. Lagares Tena L, García Monclús S, López Alemany R, Almacellas Rabaiget O, Huertas Martínez J, Sáinz Jaspeado M, et al. Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway. Oncotarget. 2016;7:56889-56903 pubmed 出版商
  197. Jiang Q, Chen S, Hu C, Huang P, Shen H, Zhao W. Neuregulin-1 (Nrg1) signaling has a preventive role and is altered in the frontal cortex under the pathological conditions of Alzheimer's disease. Mol Med Rep. 2016;14:2614-24 pubmed 出版商
  198. Di Siena S, Gimmelli R, Nori S, Barbagallo F, Campolo F, Dolci S, et al. Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury. Cell Death Dis. 2016;7:e2317 pubmed 出版商
  199. Ho J, Hsu R, Wu C, Liao G, Gao H, Wang T, et al. Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2. Oncotarget. 2016;7:53853-53868 pubmed 出版商
  200. Shi K, Qian J, Qi L, Mao D, Chen Y, Zhu Y, et al. Atorvastatin antagonizes the visfatin-induced expression of inflammatory mediators via the upregulation of NF-?B activation in HCAECs. Oncol Lett. 2016;12:1438-1444 pubmed
  201. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed 出版商
  202. Kojima Y, Volkmer J, McKenna K, Civelek M, Lusis A, Miller C, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86-90 pubmed
  203. Raguz J, Jerić I, Niault T, Nowacka J, Kuzet S, Rupp C, et al. Epidermal RAF prevents allergic skin disease. elife. 2016;5: pubmed 出版商
  204. Inda C, Dos Santos Claro P, Bonfiglio J, Senin S, Maccarrone G, Turck C, et al. Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling. J Cell Biol. 2016;214:181-95 pubmed 出版商
  205. Fresco V, Kern C, Mohammadi M, Twal W. Fibulin-1 Binds to Fibroblast Growth Factor 8 with High Affinity: EFFECTS ON EMBRYO SURVIVAL. J Biol Chem. 2016;291:18730-9 pubmed 出版商
  206. Köchl R, Thelen F, Vanes L, Brazão T, Fountain K, Xie J, et al. WNK1 kinase balances T cell adhesion versus migration in vivo. Nat Immunol. 2016;17:1075-83 pubmed 出版商
  207. Wang C, Guo S, Wang J, Yan X, Farrelly M, Zhang Y, et al. Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922. Oncotarget. 2016;7:49597-49610 pubmed 出版商
  208. Elzi D, Song M, Blackman B, Weintraub S, Lopez Terrada D, Chen Y, et al. FGF19 functions as autocrine growth factor for hepatoblastoma. Genes Cancer. 2016;7:125-35 pubmed 出版商
  209. Chen Y, LaMarche M, Chan H, Fekkes P, García Fortanet J, Acker M, et al. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature. 2016;535:148-52 pubmed
  210. Madureira P, Bharadwaj A, Bydoun M, Garant K, O Connell P, Lee P, et al. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10. Oncotarget. 2016;7:47720-47737 pubmed 出版商
  211. Zhao Y, Li Y, Luo P, Gao Y, Yang J, Lao K, et al. XBP1 splicing triggers miR-150 transfer from smooth muscle cells to endothelial cells via extracellular vesicles. Sci Rep. 2016;6:28627 pubmed 出版商
  212. Aguilera O, Muñoz Sagastibelza M, Torrejón B, Borrero Palacios A, del Puerto Nevado L, Martínez Useros J, et al. Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer. Oncotarget. 2016;7:47954-47965 pubmed 出版商
  213. Gautheron J, Vucur M, Schneider A, Severi I, Roderburg C, Roy S, et al. The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance. Nat Commun. 2016;7:11869 pubmed 出版商
  214. Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed 出版商
  215. Maugeri G, D Amico A, Reitano R, Magro G, Cavallaro S, Salomone S, et al. PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression. Front Pharmacol. 2016;7:139 pubmed 出版商
  216. Zhai W, Chen D, Shen H, Chen Z, Li H, Yu Z, et al. A1 adenosine receptor attenuates intracerebral hemorrhage-induced secondary brain injury in rats by activating the P38-MAPKAP2-Hsp27 pathway. Mol Brain. 2016;9:66 pubmed 出版商
  217. Hey F, Giblett S, Forrest S, Herbert C, Pritchard C. Phosphorylations of Serines 21/9 in Glycogen Synthase Kinase 3α/β Are Not Required for Cell Lineage Commitment or WNT Signaling in the Normal Mouse Intestine. PLoS ONE. 2016;11:e0156877 pubmed 出版商
  218. Wang J, Farris A, Xu K, Wang P, Zhang X, Duong D, et al. GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis. Nat Commun. 2016;7:11795 pubmed 出版商
  219. Schütz I, López Hernández T, Gao Q, Puchkov D, Jabs S, Nordmeyer D, et al. Lysosomal Dysfunction Caused by Cellular Accumulation of Silica Nanoparticles. J Biol Chem. 2016;291:14170-84 pubmed 出版商
  220. Yu H. Sphingosine-1-Phosphate Receptor 2 Regulates Proinflammatory Cytokine Production and Osteoclastogenesis. PLoS ONE. 2016;11:e0156303 pubmed 出版商
  221. Blee A, Liu S, Wang L, Huang H. BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion. Oncotarget. 2016;7:38319-38332 pubmed 出版商
  222. Hanson R, Brown R, Steele M, Grandgenett P, Grunkemeyer J, Hollingsworth M. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis. Oncotarget. 2016;7:39996-40011 pubmed 出版商
  223. Yang Z, Jiang Q, Chen S, Hu C, Shen H, Huang P, et al. Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model. Mol Med Rep. 2016;14:790-6 pubmed 出版商
  224. Zhang C, Li L, Zhao B, Jiao A, Li X, Sun N, et al. Ghrelin Protects against Dexamethasone-Induced INS-1 Cell Apoptosis via ERK and p38MAPK Signaling. Int J Endocrinol. 2016;2016:4513051 pubmed 出版商
  225. Hudson C, McArdle C, López Bernal A. Steroid receptor co-activator interacting protein (SIP) mediates EGF-stimulated expression of the prostaglandin synthase COX2 and prostaglandin release in human myometrium. Mol Hum Reprod. 2016;22:512-25 pubmed 出版商
  226. Wu Y, Lan C, Ren D, Chen G. Induction of Siglec-1 by Endotoxin Tolerance Suppresses the Innate Immune Response by Promoting TGF-?1 Production. J Biol Chem. 2016;291:12370-82 pubmed 出版商
  227. Choi H, Kim M, Choi Y, Shin Y, Cho S, Ko S. Rhus verniciflua Stokes (RVS) and butein induce apoptosis of paclitaxel-resistant SKOV-3/PAX ovarian cancer cells through inhibition of AKT phosphorylation. BMC Complement Altern Med. 2016;16:122 pubmed 出版商
  228. Kim S, Choi K, Cho S, Yun S, Jeon J, Koh Y, et al. Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors. Sci Rep. 2016;6:24933 pubmed 出版商
  229. Mendel I, Yacov N, Shoham A, Ishai E, Breitbart E. Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis. Dig Dis Sci. 2016;61:2545-53 pubmed 出版商
  230. Yu Z, Chen T, Li X, Yang M, Tang S, Zhu X, et al. Lys29-linkage of ASK1 by Skp1-Cullin 1-Fbxo21 ubiquitin ligase complex is required for antiviral innate response. elife. 2016;5: pubmed 出版商
  231. Macritchie N, Volpert G, Al Washih M, Watson D, Futerman A, Kennedy S, et al. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension. Cell Signal. 2016;28:946-55 pubmed 出版商
  232. Maselli A, Capoccia S, Pugliese P, Raggi C, Cirulli F, Fabi A, et al. Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation. Oncoimmunology. 2016;5:e1074375 pubmed
  233. Damle S, Martin R, Cross J, Conrad D. Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis. Mucosal Immunol. 2017;10:205-214 pubmed 出版商
  234. Shi C, Iura A, Terajima M, Liu F, Lyons K, Pan H, et al. Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors. Sci Rep. 2016;6:24256 pubmed 出版商
  235. Papadakis E, Barker C, Syed H, Reeves T, Schwaiger S, Stuppner H, et al. The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ. Oncogenesis. 2016;5:e215 pubmed 出版商
  236. Alemán O, Mora N, Cortés Vieyra R, Uribe Querol E, Rosales C. Differential Use of Human Neutrophil Fc? Receptors for Inducing Neutrophil Extracellular Trap Formation. J Immunol Res. 2016;2016:2908034 pubmed 出版商
  237. Maugeri G, D Amico A, Rasà D, Reitano R, Saccone S, Federico C, et al. Expression profile of Wilms Tumor 1 (WT1) isoforms in undifferentiated and all-trans retinoic acid differentiated neuroblastoma cells. Genes Cancer. 2016;7:47-58 pubmed
  238. Huang J, Yao C, Chuang S, Yeh C, Lee L, Chen R, et al. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. BMC Cancer. 2016;16:245 pubmed 出版商
  239. Margaryan N, Gilgur A, Seftor E, Purnell C, Arva N, Gosain A, et al. Melanocytes Affect Nodal Expression and Signaling in Melanoma Cells: A Lesson from Pediatric Large Congenital Melanocytic Nevi. Int J Mol Sci. 2016;17:418 pubmed 出版商
  240. Yang Y, Xu J, Chen H, Fei X, Tang Y, Yan Y, et al. MiR-128-2 inhibits common lymphoid progenitors from developing into progenitor B cells. Oncotarget. 2016;7:17520-31 pubmed 出版商
  241. Sakakini N, Turchi L, Bergon A, Holota H, Rekima S, Lopez F, et al. A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells. J Biol Chem. 2016;291:10684-99 pubmed 出版商
  242. Relic B, Charlier E, Deroyer C, Malaise O, Neuville S, Desoroux A, et al. BAY 11-7085 induces glucocorticoid receptor activation and autophagy that collaborate with apoptosis to induce human synovial fibroblast cell death. Oncotarget. 2016;7:23370-82 pubmed 出版商
  243. Lee J, Kim H, Rho S, Lee S. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells. Oncotarget. 2016;7:18541-57 pubmed 出版商
  244. Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, et al. Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat Commun. 2016;7:11030 pubmed 出版商
  245. Obino D, Farina F, Malbec O, Sáez P, Maurin M, Gaillard J, et al. Actin nucleation at the centrosome controls lymphocyte polarity. Nat Commun. 2016;7:10969 pubmed 出版商
  246. Morena D, Maestro N, Bersani F, Forni P, Lingua M, Foglizzo V, et al. Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes. elife. 2016;5: pubmed 出版商
  247. Acharya M, Sokolovska A, Tam J, Conway K, Stefani C, Raso F, et al. αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells. Nat Commun. 2016;7:10917 pubmed 出版商
  248. Yang H, Vainshtein A, Maik Rachline G, Peles E. G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination. Nat Commun. 2016;7:10884 pubmed 出版商
  249. Atiq R, Hertz R, Eldad S, Smeir E, Bar Tana J. Suppression of B-Raf(V600E) cancers by MAPK hyper-activation. Oncotarget. 2016;7:18694-704 pubmed 出版商
  250. Thakur A, Nigri J, Lac S, Leca J, Bressy C, Berthezene P, et al. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death Differ. 2016;23:1358-70 pubmed 出版商
  251. Naik E, Dixit V. Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCβ Kinase Activity. J Immunol. 2016;196:3438-51 pubmed 出版商
  252. Yang W, Yang Y, Yang J, Liang M, Song J. Treatment with bone marrow mesenchymal stem cells combined with plumbagin alleviates spinal cord injury by affecting oxidative stress, inflammation, apoptotis and the activation of the Nrf2 pathway. Int J Mol Med. 2016;37:1075-82 pubmed 出版商
  253. Bigenzahn J, Fauster A, Rebsamen M, Kandasamy R, Scorzoni S, Vladimer G, et al. An Inducible Retroviral Expression System for Tandem Affinity Purification Mass-Spectrometry-Based Proteomics Identifies Mixed Lineage Kinase Domain-like Protein (MLKL) as an Heat Shock Protein 90 (HSP90) Client. Mol Cell Proteomics. 2016;15:1139-50 pubmed
  254. Woo J, Srikanth S, Nishi M, Ping P, Takeshima H, Gwack Y. Junctophilin-4, a component of the endoplasmic reticulum-plasma membrane junctions, regulates Ca2+ dynamics in T cells. Proc Natl Acad Sci U S A. 2016;113:2762-7 pubmed 出版商
  255. Eriksson J, Le Joncour V, Nummela P, Jahkola T, Virolainen S, Laakkonen P, et al. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression. Oncotarget. 2016;7:15065-92 pubmed 出版商
  256. Abdul Rahman N, Greenwood S, Brett R, Tossell K, Ungless M, Plevin R, et al. Mitogen-Activated Protein Kinase Phosphatase-2 Deletion Impairs Synaptic Plasticity and Hippocampal-Dependent Memory. J Neurosci. 2016;36:2348-54 pubmed 出版商
  257. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed 出版商
  258. Huo L, Shi W, Chong L, Wang J, Zhang K, Li Y. Asiatic acid inhibits left ventricular remodeling and improves cardiac function in a rat model of myocardial infarction. Exp Ther Med. 2016;11:57-64 pubmed
  259. Kline C, van den Heuvel A, Allen J, Prabhu V, Dicker D, El Deiry W. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. Sci Signal. 2016;9:ra18 pubmed 出版商
  260. Wang J, Goetsch L, Tucker L, Zhang Q, Gonzalez A, Vaidya K, et al. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer. 2016;16:105 pubmed 出版商
  261. Krause C, Popp O, Thirunarayanan N, Dittmar G, Lipp M, Müller G. MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR. Oncotarget. 2016;7:10414-32 pubmed 出版商
  262. Ebbing E, Medema J, Damhofer H, Meijer S, Krishnadath K, van Berge Henegouwen M, et al. ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3. Oncotarget. 2016;7:10243-54 pubmed 出版商
  263. Li S, Lu L, Liao X, Gao T, Wang F, Zhang L, et al. Manganese elevates manganese superoxide dismutase protein level through protein kinase C and protein tyrosine kinase. Biometals. 2016;29:265-74 pubmed 出版商
  264. Däbritz J, Judd L, Chalinor H, Menheniott T, Giraud A. Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells. Sci Rep. 2016;6:20584 pubmed 出版商
  265. Coke C, Scarlett K, Chetram M, Jones K, Sandifer B, Davis A, et al. Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression. J Biol Chem. 2016;291:9991-10005 pubmed 出版商
  266. Martin B, Chadwick W, Janssens J, Premont R, Schmalzigaug R, Becker K, et al. GIT2 Acts as a Systems-Level Coordinator of Neurometabolic Activity and Pathophysiological Aging. Front Endocrinol (Lausanne). 2015;6:191 pubmed 出版商
  267. Liu L, Zhu J, Zhou L, Wan L. RACK1 promotes maintenance of morphine-associated memory via activation of an ERK-CREB dependent pathway in hippocampus. Sci Rep. 2016;6:20183 pubmed 出版商
  268. Dorris E, Blackshields G, Sommerville G, Alhashemi M, Dias A, McEneaney V, et al. Pluripotency markers are differentially induced by MEK inhibition in thyroid and melanoma BRAFV600E cell lines. Cancer Biol Ther. 2016;17:526-42 pubmed 出版商
  269. Theodosiou M, Widmaier M, Böttcher R, Rognoni E, Veelders M, Bharadwaj M, et al. Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin. elife. 2016;5:e10130 pubmed 出版商
  270. Stefanovic M, Tutusaus A, Martinez Nieto G, Bárcena C, de Gregorio E, Moutinho C, et al. Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma. Oncotarget. 2016;7:8253-67 pubmed 出版商
  271. Peres T, Ong L, Costa A, Eyng H, Venske D, Colle D, et al. Tyrosine hydroxylase regulation in adult rat striatum following short-term neonatal exposure to manganese. Metallomics. 2016;8:597-604 pubmed 出版商
  272. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam K, et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS ONE. 2016;11:e0147344 pubmed 出版商
  273. Chan A, Punwani D, Kadlecek T, Cowan M, Olson J, Mathes E, et al. A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J Exp Med. 2016;213:155-65 pubmed 出版商
  274. Lv P, Tong X, Peng Q, Liu Y, Jin H, Liu R, et al. Treatment with the herbal medicine, naoxintong improves the protective effect of high-density lipoproteins on endothelial function in patients with type 2 diabetes. Mol Med Rep. 2016;13:2007-16 pubmed 出版商
  275. Chen Y, Zheng Y, You X, Yu M, Fu G, Su X, et al. Kras Is Critical for B Cell Lymphopoiesis. J Immunol. 2016;196:1678-85 pubmed 出版商
  276. Peng K, Tian X, Qian Y, Skibba M, Zou C, Liu Z, et al. Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II. J Cell Mol Med. 2016;20:482-94 pubmed 出版商
  277. Daniele S, Barresi E, Zappelli E, Marinelli L, Novellino E, Da Settimo F, et al. Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells. Oncotarget. 2016;7:7866-84 pubmed 出版商
  278. Pivonello C, Negri M, De Martino M, Napolitano M, De Angelis C, Provvisiero D, et al. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma. Oncotarget. 2016;7:9718-31 pubmed 出版商
  279. Lin C, Wang C, Hsu S, Liao L, Lin T, Hsueh C. Molecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic Brain. PLoS ONE. 2016;11:e0146692 pubmed 出版商
  280. Matalkah F, Martin E, Zhao H, Agazie Y. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer. Breast Cancer Res. 2016;18:2 pubmed 出版商
  281. Yamaguchi T, Lu C, Ida L, Yanagisawa K, Usukura J, Cheng J, et al. ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nat Commun. 2016;7:10060 pubmed 出版商
  282. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed 出版商
  283. Hernandez R, Puro A, Manos J, Huitron Resendiz S, Reyes K, Liu K, et al. Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function. Neuropharmacology. 2016;103:27-43 pubmed 出版商
  284. Fan S, Numata Y, Numata M. Endosomal Na+/H+ exchanger NHE5 influences MET recycling and cell migration. Mol Biol Cell. 2016;27:702-15 pubmed 出版商
  285. Shih M, Pan K, Cherng J. Possible Mechanisms of Di(2-ethylhexyl) Phthalate-Induced MMP-2 and MMP-9 Expression in A7r5 Rat Vascular Smooth Muscle Cells. Int J Mol Sci. 2015;16:28800-11 pubmed 出版商
  286. Sun J, Fu X, Liu Y, Wang Y, Huo B, Guo Y, et al. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice. Drug Des Devel Ther. 2015;9:6327-42 pubmed 出版商
  287. Drilon A, Somwar R, Wagner J, Vellore N, Eide C, Zabriskie M, et al. A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer. Clin Cancer Res. 2016;22:2351-8 pubmed 出版商
  288. Huguet F, Fernet M, Giocanti N, Favaudon V, Larsen A. Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status. Target Oncol. 2016;11:371-81 pubmed 出版商
  289. Franco Villanueva A, Wandosell F, Antón I. Neuritic complexity of hippocampal neurons depends on WIP-mediated mTORC1 and Abl family kinases activities. Brain Behav. 2015;5:e00359 pubmed 出版商
  290. Audette D, Anand D, So T, Rubenstein T, Lachke S, Lovicu F, et al. Prox1 and fibroblast growth factor receptors form a novel regulatory loop controlling lens fiber differentiation and gene expression. Development. 2016;143:318-28 pubmed 出版商
  291. Daniele S, Zappelli E, Martini C. Trazodone regulates neurotrophic/growth factors, mitogen-activated protein kinases and lactate release in human primary astrocytes. J Neuroinflammation. 2015;12:225 pubmed 出版商
  292. Duchnowska R, Wysocki P, Korski K, Czartoryska ArÅ‚ukowicz B, NiwiÅ„ska A, Orlikowska M, et al. Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients. Oncotarget. 2016;7:550-64 pubmed 出版商
  293. Bunda S, Burrell K, Heir P, Zeng L, Alamsahebpour A, Kano Y, et al. Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis. Nat Commun. 2015;6:8859 pubmed 出版商
  294. Debruyne D, Bhatnagar N, Sharma B, Luther W, Moore N, Cheung N, et al. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT. Oncogene. 2016;35:3681-91 pubmed 出版商
  295. Lim J, Nguyen K, Han J, Jang I, Fabian C, Cho K. Direct Regulation of TLR5 Expression by Caveolin-1. Mol Cells. 2015;38:1111-7 pubmed 出版商
  296. Giri K, Pabelick C, Mukherjee P, Prakash Y. Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells. Apoptosis. 2016;21:329-39 pubmed 出版商
  297. Wang Z, Ma B, Li H, Xiao X, Zhou W, Liu F, et al. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC. Oncotarget. 2016;7:509-23 pubmed 出版商
  298. Shukla P, Vogl C, Wallner B, Rigler D, Müller M, Macho Maschler S. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells. BMC Genomics. 2015;16:944 pubmed 出版商
  299. Ampofo E, Später T, Müller I, Eichler H, Menger M, Laschke M. The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity. Mar Drugs. 2015;13:6774-91 pubmed 出版商
  300. Quintero Barceinas R, García Regalado A, Aréchaga Ocampo E, Villegas Sepúlveda N, González De la Rosa C. All-Trans Retinoic Acid Induces Proliferation, Survival, and Migration in A549 Lung Cancer Cells by Activating the ERK Signaling Pathway through a Transcription-Independent Mechanism. Biomed Res Int. 2015;2015:404368 pubmed 出版商
  301. Ksionda O, Melton A, Bache J, Tenhagen M, Bakker J, Harvey R, et al. RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines. Oncogene. 2016;35:3658-68 pubmed 出版商
  302. Yen Y, Hsiao J, Jiang S, Chang J, Wang S, Shen Y, et al. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1. Oncotarget. 2015;6:41837-55 pubmed 出版商
  303. Vernot J, Perdomo Arciniegas A, Pérez Quintero L, Martínez D. Modulating p56Lck in T-Cells by a Chimeric Peptide Comprising Two Functionally Different Motifs of Tip from Herpesvirus saimiri. J Immunol Res. 2015;2015:395371 pubmed 出版商
  304. Li W, Wei S, Liu C, Song M, Wu H, Yang Y. Regulation of the osteogenic and adipogenic differentiation of bone marrow-derived stromal cells by extracellular uridine triphosphate: The role of P2Y2 receptor and ERK1/2 signaling. Int J Mol Med. 2016;37:63-73 pubmed 出版商
  305. Freedman T, Tan Y, Skrzypczynska K, Manz B, Sjaastad F, Goodridge H, et al. LynA regulates an inflammation-sensitive signaling checkpoint in macrophages. elife. 2015;4: pubmed 出版商
  306. Sipieter F, Cappe B, Gonzalez Pisfil M, Spriet C, Bodart J, Cailliau Maggio K, et al. Novel Reporter for Faithful Monitoring of ERK2 Dynamics in Living Cells and Model Organisms. PLoS ONE. 2015;10:e0140924 pubmed 出版商
  307. Ko T, Chin H, Chuah C, Huang J, Ng K, Khaw S, et al. The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia. Oncotarget. 2016;7:2721-33 pubmed 出版商
  308. Wu S, Guo Z, Hopkins C, Wei N, Chu E, Wipf P, et al. Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells. Oncotarget. 2015;6:40866-79 pubmed 出版商
  309. Ramcharan R, Aleksic T, Kamdoum W, Gao S, Pfister S, Tanner J, et al. IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide. Oncotarget. 2015;6:39877-90 pubmed 出版商
  310. Bauer J, Ozden O, Akagi N, Carroll T, Principe D, Staudacher J, et al. Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer. Mol Cancer. 2015;14:182 pubmed 出版商
  311. Hruska M, Henderson N, Xia N, Le Marchand S, Dalva M. Anchoring and synaptic stability of PSD-95 is driven by ephrin-B3. Nat Neurosci. 2015;18:1594-605 pubmed 出版商
  312. Strizzi L, Sandomenico A, Margaryan N, Focà A, Sanguigno L, Bodenstine T, et al. Effects of a novel Nodal-targeting monoclonal antibody in melanoma. Oncotarget. 2015;6:34071-86 pubmed 出版商
  313. Barbáchano A, Fernández Barral A, Pereira F, Segura M, Ordóñez Morán P, Carrillo de Santa Pau E, et al. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150. Oncogene. 2016;35:2991-3003 pubmed 出版商
  314. Salas E, Roy S, Marsh T, Rubin B, Debnath J. Oxidative pentose phosphate pathway inhibition is a key determinant of antimalarial induced cancer cell death. Oncogene. 2016;35:2913-22 pubmed 出版商
  315. Kim H, Lim J, Kim J, Kim Y, Park S, Sohn J. Panaxydol, a component of Panax ginseng, induces apoptosis in cancer cells through EGFR activation and ER stress and inhibits tumor growth in mouse models. Int J Cancer. 2016;138:1432-41 pubmed 出版商
  316. Liu L, Li C, Lu Y, Zong X, Luo C, Sun J, et al. Baclofen mediates neuroprotection on hippocampal CA1 pyramidal cells through the regulation of autophagy under chronic cerebral hypoperfusion. Sci Rep. 2015;5:14474 pubmed 出版商
  317. Sun Y, Ju M, Lin Z, Fredrick T, Evans L, Tian K, et al. SOCS3 in retinal neurons and glial cells suppresses VEGF signaling to prevent pathological neovascular growth. Sci Signal. 2015;8:ra94 pubmed 出版商
  318. Pearson H, McGlinn E, Phesse T, Schlüter H, Srikumar A, Gödde N, et al. The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis. Mol Cancer. 2015;14:169 pubmed 出版商
  319. Davare M, Vellore N, Wagner J, Eide C, Goodman J, Drilon A, et al. Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors. Proc Natl Acad Sci U S A. 2015;112:E5381-90 pubmed 出版商
  320. Xing R, Li L, Chen L, Gao Z, Wang H, Li W, et al. Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells. Oncogene. 2016;35:2584-91 pubmed 出版商
  321. Ramírez de Arellano A, Lopez Pulido E, Martínez Neri P, Estrada Chávez C, González Lucano R, Fafutis Morris M, et al. STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells. Cancer Cell Int. 2015;15:83 pubmed 出版商
  322. Zhou X, Tao Y, Liang C, Zhang Y, Li H, Chen Q. BMP3 Alone and Together with TGF-β Promote the Differentiation of Human Mesenchymal Stem Cells into a Nucleus Pulposus-Like Phenotype. Int J Mol Sci. 2015;16:20344-59 pubmed 出版商
  323. Higa Nakamine S, Maeda N, Toku S, Yamamoto H. Involvement of Protein Kinase D1 in Signal Transduction from the Protein Kinase C Pathway to the Tyrosine Kinase Pathway in Response to Gonadotropin-releasing Hormone. J Biol Chem. 2015;290:25974-85 pubmed 出版商
  324. Georgiannakis A, Burgoyne T, Lueck K, Futter C, Greenwood J, Moss S. Retinal Pigment Epithelial Cells Mitigate the Effects of Complement Attack by Endocytosis of C5b-9. J Immunol. 2015;195:3382-9 pubmed 出版商
  325. Gong Y, Qiu W, Ning X, Yang X, Liu L, Wang Z, et al. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration. Oncotarget. 2015;6:25856-67 pubmed 出版商
  326. Kumarasamy V, Shin Y, White J, Sun D. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine. BMC Cancer. 2015;15:599 pubmed 出版商
  327. Wong T, Lin S, Leung L. The Flavone Luteolin Suppresses SREBP-2 Expression and Post-Translational Activation in Hepatic Cells. PLoS ONE. 2015;10:e0135637 pubmed 出版商
  328. Zhao C, Su Y, Zhang J, Feng Q, Qu L, Wang L, et al. Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis. Cancer Sci. 2015;106:1596-606 pubmed 出版商
  329. Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature. 2015;525:389-393 pubmed 出版商
  330. Park E, Kim N, Ficarro S, Zhang Y, Lee B, Cho A, et al. Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6. Nat Struct Mol Biol. 2015;22:703-711 pubmed 出版商
  331. Sivaraj K, Li R, Albarrán Juárez J, Wang S, Tischner D, Grimm M, et al. Endothelial Gαq/11 is required for VEGF-induced vascular permeability and angiogenesis. Cardiovasc Res. 2015;108:171-80 pubmed 出版商
  332. Sun D, Buttitta L. Protein phosphatase 2A promotes the transition to G0 during terminal differentiation in Drosophila. Development. 2015;142:3033-45 pubmed 出版商
  333. Kim K, Byeon G, Kim H, Baek S, Shin S, Koo S. Mechanical Antiallodynic Effect of Intrathecal Nefopam in a Rat Neuropathic Pain Model. J Korean Med Sci. 2015;30:1189-96 pubmed 出版商
  334. Patel P, Dutta D, Edgar B. Niche appropriation by Drosophila intestinal stem cell tumours. Nat Cell Biol. 2015;17:1182-92 pubmed 出版商
  335. Wu M, Lee W, Hua K, Kuo M, Lin M. Macrophage Infiltration Induces Gastric Cancer Invasiveness by Activating the β-Catenin Pathway. PLoS ONE. 2015;10:e0134122 pubmed 出版商
  336. Zhang W, Zheng X, Du L, Sun J, Shen Z, Shi C, et al. High salt primes a specific activation state of macrophages, M(Na). Cell Res. 2015;25:893-910 pubmed 出版商
  337. Zou Q, Jin J, Xiao Y, Hu H, Zhou X, Jie Z, et al. T cell development involves TRAF3IP3-mediated ERK signaling in the Golgi. J Exp Med. 2015;212:1323-36 pubmed 出版商
  338. García Pérez D, Laorden M, Milanés M. Regulation of Pleiotrophin, Midkine, Receptor Protein Tyrosine Phosphatase β/ζ, and Their Intracellular Signaling Cascades in the Nucleus Accumbens During Opiate Administration. Int J Neuropsychopharmacol. 2015;19: pubmed 出版商
  339. Gorojod R, Alaimo A, Porte Alcon S, Pomilio C, Saravia F, Kotler M. The autophagic- lysosomal pathway determines the fate of glial cells under manganese- induced oxidative stress conditions. Free Radic Biol Med. 2015;87:237-51 pubmed 出版商
  340. Yang S, Lin H, Chang V, Chen C, Liu Y, Wang J, et al. Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo. Oncotarget. 2015;6:23857-73 pubmed
  341. Xiong H, Zhou S, Sun A, He Y, Li J, Yuan X. MicroRNA‑197 reverses the drug resistance of fluorouracil‑induced SGC7901 cells by targeting mitogen‑activated protein kinase 1. Mol Med Rep. 2015;12:5019-25 pubmed 出版商
  342. Seo G, Ho M, Bui N, Kim Y, Koh D, Lim Y, et al. Novel naphthochalcone derivative accelerate dermal wound healing through induction of epithelial-mesenchymal transition of keratinocyte. J Biomed Sci. 2015;22:47 pubmed 出版商
  343. He L, Zang A, Du M, Ma D, Yuan C, Zhou C, et al. mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines. Virol Sin. 2015;30:174-89 pubmed 出版商
  344. Noda K, Mishina Y, Komatsu Y. Constitutively active mutation of ACVR1 in oral epithelium causes submucous cleft palate in mice. Dev Biol. 2016;415:306-313 pubmed 出版商
  345. Roda D, Castillo J, Telechea Fernández M, Gil A, López Rodas G, Franco L, et al. EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells. PLoS ONE. 2015;10:e0130543 pubmed 出版商
  346. Westcot S, Hatzold J, Urban M, Richetti S, Skuster K, Harm R, et al. Protein-Trap Insertional Mutagenesis Uncovers New Genes Involved in Zebrafish Skin Development, Including a Neuregulin 2a-Based ErbB Signaling Pathway Required during Median Fin Fold Morphogenesis. PLoS ONE. 2015;10:e0130688 pubmed 出版商
  347. Pickard A, McDade S, McFarland M, McCluggage W, Wheeler C, McCance D. HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures. PLoS Pathog. 2015;11:e1004988 pubmed 出版商
  348. Choi J, Kim J, Kim T, Park J, Lee J, Kim H, et al. TRH and TRH receptor system in the basolateral amygdala mediate stress-induced depression-like behaviors. Neuropharmacology. 2015;97:346-56 pubmed 出版商
  349. Chen M, Yen C, Cheng C, Wu R, Huang S, Yu C, et al. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma. Oncotarget. 2015;6:23594-608 pubmed
  350. Faggi F, Codenotti S, Poliani P, Cominelli M, Chiarelli N, Colombi M, et al. MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line. PLoS ONE. 2015;10:e0130287 pubmed 出版商
  351. Gopinathan G, Milagre C, Pearce O, Reynolds L, Hodivala Dilke K, Leinster D, et al. Interleukin-6 Stimulates Defective Angiogenesis. Cancer Res. 2015;75:3098-107 pubmed 出版商
  352. Nan X, Tamgüney T, Collisson E, Lin L, Pitt C, Galeas J, et al. Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway. Proc Natl Acad Sci U S A. 2015;112:7996-8001 pubmed 出版商
  353. Hensel J, Duex J, Owens C, Dancik G, Edwards M, Frierson H, et al. Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors. Mol Cancer Res. 2015;13:1306-15 pubmed 出版商
  354. Lee W, Shen S, Shih Y, Chou C, Tseng J, Chin S, et al. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts. J Transl Med. 2015;13:191 pubmed 出版商
  355. Unni A, Lockwood W, Zejnullahu K, Lee Lin S, Varmus H. Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma. elife. 2015;4:e06907 pubmed 出版商
  356. Wightman S, Uppal A, Pitroda S, Ganai S, Burnette B, Stack M, et al. Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome. Br J Cancer. 2015;113:327-35 pubmed 出版商
  357. García Cano J, Ambroise G, Pascual Serra R, Carrión M, Serrano Oviedo L, Ortega Muelas M, et al. Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance. Oncotarget. 2015;6:15551-65 pubmed
  358. Boeldt D, Grummer M, YI F, Magness R, Bird I. Phosphorylation of Ser-279/282 and Tyr-265 positions on Cx43 as possible mediators of VEGF-165 inhibition of pregnancy-adapted Ca2+ burst function in ovine uterine artery endothelial cells. Mol Cell Endocrinol. 2015;412:73-84 pubmed 出版商
  359. Tampella G, Kerns H, Niu D, Singh S, Khim S, Bosch K, et al. The Tec Kinase-Regulated Phosphoproteome Reveals a Mechanism for the Regulation of Inhibitory Signals in Murine Macrophages. J Immunol. 2015;195:246-56 pubmed 出版商
  360. Li T, Lu H, Mukherjee D, Lahiri S, Shen C, Yu L, et al. Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer. Oncotarget. 2015;6:21428-42 pubmed
  361. Luan Q, Jin L, Jiang C, Tay K, Lai F, Liu X, et al. RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy. Autophagy. 2015;11:975-94 pubmed 出版商
  362. Yen C, Chiang W, Liu S, Lin C, Liao K, Lin C, et al. Impacts of autophagy-inducing ingredient of areca nut on tumor cells. PLoS ONE. 2015;10:e0128011 pubmed 出版商
  363. Korotkevych N, Labyntsev A, Kolybo D, Komisarenko S. The Soluble Heparin-Binding EGF-Like Growth Factor Stimulates EGF Receptor Trafficking to the Nucleus. PLoS ONE. 2015;10:e0127887 pubmed 出版商
  364. Reigada D, Nieto Díaz M, Navarro Ruiz R, Caballero López M, Del Águila A, Muñoz Galdeano T, et al. Acute administration of ucf-101 ameliorates the locomotor impairments induced by a traumatic spinal cord injury. Neuroscience. 2015;300:404-17 pubmed 出版商
  365. Bargut T, Mandarim de Lacerda C, Aguila M. A high-fish-oil diet prevents adiposity and modulates white adipose tissue inflammation pathways in mice. J Nutr Biochem. 2015;26:960-9 pubmed 出版商
  366. Greenfeld H, Takasaki K, Walsh M, Ersing I, Bernhardt K, Ma Y, et al. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation. PLoS Pathog. 2015;11:e1004890 pubmed 出版商
  367. Li P, Sheu M, Ma W, Pan C, Sheu J, Wu C. Anti-Restenotic Roles of Dihydroaustrasulfone Alcohol Involved in Inhibiting PDGF-BB-Stimulated Proliferation and Migration of Vascular Smooth Muscle Cells. Mar Drugs. 2015;13:3046-60 pubmed 出版商
  368. Pan D, Jiang C, Ma Z, Blonska M, You M, Lin X. MALT1 is required for EGFR-induced NF-?B activation and contributes to EGFR-driven lung cancer progression. Oncogene. 2016;35:919-28 pubmed 出版商
  369. Ji X, Li Z, Chen H, Li J, Tian H, Li Z, et al. Cytotoxic mechanism related to dihydrolipoamide dehydrogenase in Leydig cells exposed to heavy metals. Toxicology. 2015;334:22-32 pubmed 出版商
  370. Wong T, Lin S, Leung L. The flavone apigenin blocks nuclear translocation of sterol regulatory element-binding protein-2 in the hepatic cells WRL-68. Br J Nutr. 2015;113:1844-52 pubmed 出版商
  371. Ketema M, Secades P, Kreft M, Nahidiazar L, Janssen H, Jalink K, et al. The rod domain is not essential for the function of plectin in maintaining tissue integrity. Mol Biol Cell. 2015;26:2402-17 pubmed 出版商
  372. Andersen N, Boguslawski E, Kuk C, Chambers C, Duesbery N. Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts. Int J Oncol. 2015;47:71-80 pubmed 出版商
  373. Cong X, Zhang Y, Li J, Mei M, Ding C, Xiang R, et al. Claudin-4 is required for modulation of paracellular permeability by muscarinic acetylcholine receptor in epithelial cells. J Cell Sci. 2015;128:2271-86 pubmed 出版商
  374. Rios Doria J, Sabol D, Chesebrough J, Stewart D, Xu L, Tammali R, et al. A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways. Mol Cancer Ther. 2015;14:1637-49 pubmed 出版商
  375. Yu Y, Koehn C, Yue Y, Li S, Thiele G, Hearth Holmes M, et al. Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation. Curr Mol Med. 2015;15:401-10 pubmed
  376. Lee E, Park E, Mun H, Chang E, Ko J, Kim D, et al. Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation. FASEB J. 2015;29:3506-14 pubmed 出版商
  377. Bhang S, Han J, Jang H, Noh M, La W, Yi M, et al. pH-triggered release of manganese from MnAu nanoparticles that enables cellular neuronal differentiation without cellular toxicity. Biomaterials. 2015;55:33-43 pubmed 出版商
  378. SCANLON C, Banerjee R, Inglehart R, Liu M, Russo N, Hariharan A, et al. Galanin modulates the neural niche to favour perineural invasion in head and neck cancer. Nat Commun. 2015;6:6885 pubmed 出版商
  379. Pasqualon T, Pruessmeyer J, Weidenfeld S, Babendreyer A, Groth E, Schumacher J, et al. A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation. Cell Mol Life Sci. 2015;72:3783-801 pubmed 出版商
  380. Daniele S, Da Pozzo E, Zappelli E, Martini C. Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-?B, p38 and JNK. Cell Signal. 2015;27:1609-29 pubmed 出版商
  381. Chan S, Selth L, Li Y, Nyquist M, Miao L, Bradner J, et al. Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies. Nucleic Acids Res. 2015;43:5880-97 pubmed 出版商
  382. Huang L, Counter C. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S. PLoS ONE. 2015;10:e0123918 pubmed 出版商
  383. Yang Z, Zheng B, Zhang Y, He M, Zhang X, Ma D, et al. miR-155-dependent regulation of mammalian sterile 20-like kinase 2 (MST2) coordinates inflammation, oxidative stress and proliferation in vascular smooth muscle cells. Biochim Biophys Acta. 2015;1852:1477-89 pubmed 出版商
  384. Selvaraj N, Kedage V, Hollenhorst P. Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells. Cell Commun Signal. 2015;13:12 pubmed 出版商
  385. Zhang X, Liang D, Chi Z, Chu Q, Zhao C, Ma R, et al. Effect of zinc on high glucose-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells. Int J Mol Med. 2015;35:1747-54 pubmed 出版商
  386. Hayashi Y, Bardsley M, Toyomasu Y, Milosavljevic S, Gajdos G, Choi K, et al. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1. Gastroenterology. 2015;149:420-32.e16 pubmed 出版商
  387. Navis A, van Lith S, van Duijnhoven S, de Pooter M, Yetkin Arik B, Wesseling P, et al. Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein. Acta Neuropathol. 2015;130:131-44 pubmed 出版商
  388. Witkiewicz A, McMillan E, Balaji U, Baek G, Lin W, Mansour J, et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun. 2015;6:6744 pubmed 出版商
  389. Kim T, Lawson M. GnRH Regulates Gonadotropin Gene Expression Through NADPH/Dual Oxidase-Derived Reactive Oxygen Species. Endocrinology. 2015;156:2185-99 pubmed 出版商
  390. Boncompagni S, Arthurton L, Akujuru E, Pearson T, Steverding D, Protasi F, et al. Membrane glucocorticoid receptors are localised in the extracellular matrix and signal through the MAPK pathway in mammalian skeletal muscle fibres. J Physiol. 2015;593:2679-92 pubmed 出版商
  391. Brohée L, Demine S, Willems J, Arnould T, Colige A, Deroanne C. Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment. Oncotarget. 2015;6:11264-80 pubmed
  392. Chan N, He S, Spee C, Ishikawa K, Hinton D. Attenuation of choroidal neovascularization by histone deacetylase inhibitor. PLoS ONE. 2015;10:e0120587 pubmed 出版商
  393. Zhang Q, Kuang H, Chen C, Yan J, Do Umehara H, Liu X, et al. The kinase Jnk2 promotes stress-induced mitophagy by targeting the small mitochondrial form of the tumor suppressor ARF for degradation. Nat Immunol. 2015;16:458-66 pubmed 出版商
  394. Graziani G, Artuso S, De Luca A, Muzi A, Rotili D, Scimeca M, et al. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib. Biochem Pharmacol. 2015;95:16-27 pubmed 出版商
  395. Kumar A, Pathak P, Purkait S, Faruq M, Jha P, Mallick S, et al. Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas. Cancer Genet. 2015;208:91-5 pubmed 出版商
  396. Muro R, Nitta T, Okada T, Ideta H, Tsubata T, Suzuki H. The Ras GTPase-activating protein Rasal3 supports survival of naive T cells. PLoS ONE. 2015;10:e0119898 pubmed 出版商
  397. Kawada M, Inoue H, Ohba S, Yoshida J, Masuda T, Yamasaki M, et al. Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction. PLoS ONE. 2015;10:e0119415 pubmed 出版商
  398. Carnesecchi J, Malbouyres M, de Mets R, Balland M, Beauchef G, Vié K, et al. Estrogens induce rapid cytoskeleton re-organization in human dermal fibroblasts via the non-classical receptor GPR30. PLoS ONE. 2015;10:e0120672 pubmed 出版商
  399. Qu D, Chen Y, Xu X, Zhang M, Zhang Y, Li S. Cbl-b-regulated extracellular signal-regulated kinase signaling is involved in the shikonin-induced apoptosis of lung cancer cells in vitro. Exp Ther Med. 2015;9:1265-1270 pubmed
  400. Wang B, Wu S, Tang S, Lai C, Ou C, Wu M, et al. Benzo[a]pyrene-induced cell cycle progression occurs via ERK-induced Chk1 pathway activation in human lung cancer cells. Mutat Res. 2015;773:1-8 pubmed 出版商
  401. Wilson F, Johannessen C, Piccioni F, Tamayo P, Kim J, Van Allen E, et al. A functional landscape of resistance to ALK inhibition in lung cancer. Cancer Cell. 2015;27:397-408 pubmed 出版商
  402. Münzberg C, Höhn K, Krndija D, Maaß U, Bartsch D, Slater E, et al. IGF-1 drives chromogranin A secretion via activation of Arf1 in human neuroendocrine tumour cells. J Cell Mol Med. 2015;19:948-59 pubmed 出版商
  403. Warren D, Tajsic T, Porter L, Minaisah R, Cobb A, Jacob A, et al. Nesprin-2-dependent ERK1/2 compartmentalisation regulates the DNA damage response in vascular smooth muscle cell ageing. Cell Death Differ. 2015;22:1540-50 pubmed 出版商
  404. Silva G, Aboussekhra A. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1. Mol Carcinog. 2016;55:525-36 pubmed 出版商
  405. Cheng Z, Liu F, Zhu S, Tian H, Wang L, Wang Y. A rapid and convenient method for fluorescence analysis of in vitro cultivated metacestode vesicles from Echinococcus multilocularis. PLoS ONE. 2015;10:e0118215 pubmed 出版商
  406. Wnorowski A, Sadowska M, Paul R, Singh N, Boguszewska Czubara A, Jimenez L, et al. Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells. Cell Signal. 2015;27:997-1007 pubmed 出版商
  407. Murrow L, Malhotra R, Debnath J. ATG12-ATG3 interacts with Alix to promote basal autophagic flux and late endosome function. Nat Cell Biol. 2015;17:300-10 pubmed 出版商
  408. Skarra D, Thackray V. FOXO1 is regulated by insulin and IGF1 in pituitary gonadotropes. Mol Cell Endocrinol. 2015;405:14-24 pubmed 出版商
  409. Guillaumond F, Bidaut G, Ouaissi M, Servais S, Gouirand V, Olivares O, et al. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma. Proc Natl Acad Sci U S A. 2015;112:2473-8 pubmed 出版商
  410. Momeny M, Saunus J, Marturana F, McCart Reed A, Black D, Sala G, et al. Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines. Oncotarget. 2015;6:3932-46 pubmed
  411. Fouladi F, Jehn L, Metzelder S, Hub F, Henkenius K, Burchert A, et al. Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation. Leuk Lymphoma. 2015;56:2690-8 pubmed 出版商
  412. Kondapalli K, Llongueras J, Capilla González V, Prasad H, Hack A, Smith C, et al. A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma. Nat Commun. 2015;6:6289 pubmed 出版商
  413. Castorina A, Waschek J, Marzagalli R, Cardile V, Drago F. PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in schwann cell-like cultures. PLoS ONE. 2015;10:e0117799 pubmed 出版商
  414. Papadakis A, Sun C, Knijnenburg T, Xue Y, Grernrum W, Hölzel M, et al. SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer. Cell Res. 2015;25:445-58 pubmed 出版商
  415. Bai L, Mao R, Wang J, Ding L, Jiang S, Gao C, et al. ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins. Med Oncol. 2015;32:57 pubmed 出版商
  416. Shaw A, Pickup M, Chytil A, Aakre M, Owens P, Moses H, et al. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions. PLoS ONE. 2015;10:e0117908 pubmed 出版商
  417. Bele A, Mirza S, Zhang Y, Ahmad Mir R, Lin S, Kim J, et al. The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells. Cell Cycle. 2015;14:990-1000 pubmed 出版商
  418. Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz E, Cappello A, et al. Effects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblasts. Environ Health Perspect. 2015;123:493-9 pubmed 出版商
  419. Tian E, Stevens S, Guan Y, Springer D, Anderson S, Starost M, et al. Galnt1 is required for normal heart valve development and cardiac function. PLoS ONE. 2015;10:e0115861 pubmed 出版商
  420. Seaberg B, Henslee G, Wang S, Paez Colasante X, Landreth G, Rimer M. Muscle-derived extracellular signal-regulated kinases 1 and 2 are required for the maintenance of adult myofibers and their neuromuscular junctions. Mol Cell Biol. 2015;35:1238-53 pubmed 出版商
  421. Tontonoz P, Cortez Toledo O, Wroblewski K, Hong C, Lim L, Carranza R, et al. The orphan nuclear receptor Nur77 is a determinant of myofiber size and muscle mass in mice. Mol Cell Biol. 2015;35:1125-38 pubmed 出版商
  422. Schäker K, Bartsch S, Patry C, Stoll S, Hillebrands J, Wieland T, et al. The bipartite rac1 Guanine nucleotide exchange factor engulfment and cell motility 1/dedicator of cytokinesis 180 (elmo1/dock180) protects endothelial cells from apoptosis in blood vessel development. J Biol Chem. 2015;290:6408-18 pubmed 出版商
  423. de Oliveira S, Boudinot P, Calado Ã, Mulero V. Duox1-derived H2O2 modulates Cxcl8 expression and neutrophil recruitment via JNK/c-JUN/AP-1 signaling and chromatin modifications. J Immunol. 2015;194:1523-33 pubmed 出版商
  424. Majuelos Melguizo J, Rodríguez M, López Jiménez L, Rodríguez Vargas J, Martí Martín Consuegra J, Serrano Sáenz S, et al. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma. Oncotarget. 2015;6:4790-803 pubmed
  425. Cheng Y, Chen P, Chiang H, Suen C, Hwang M, Lin T, et al. Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT. Cell Death Dis. 2015;6:e1584 pubmed 出版商
  426. Sathyamurthy A, Yin D, Barik A, Shen C, Bean J, Figueiredo D, et al. ERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination. Development. 2015;142:522-32 pubmed 出版商
  427. Wang H, Zhu X, Qin L, Qian H, Wang Y. Microglia activity modulated by T cell Ig and mucin domain protein 3 (Tim-3). Cell Immunol. 2015;293:49-58 pubmed 出版商
  428. Zanotto Filho A, Braganhol E, Klafke K, Figueiró F, Terra S, Paludo F, et al. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas. Cancer Lett. 2015;358:220-31 pubmed 出版商
  429. Gonzalez Granado J, Navarro Puche A, Molina Sánchez P, Blanco Berrocal M, Viana R, Font de Mora J, et al. Sorting nexin 6 enhances lamin a synthesis and incorporation into the nuclear envelope. PLoS ONE. 2014;9:e115571 pubmed 出版商
  430. Salotti J, Sakchaisri K, Tourtellotte W, Johnson P. An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer. Mol Cell Biol. 2015;35:866-83 pubmed 出版商
  431. Passos E, Pereira C, Gonçalves I, Rocha Rodrigues S, Silva N, Guimarães J, et al. Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis. Life Sci. 2015;123:51-60 pubmed 出版商
  432. Kim E, Kim S, Jin X, Ham S, Kim J, Park J, et al. Epidermal growth factor receptor variant III renders glioma cancer cells less differentiated by JAGGED1. Tumour Biol. 2015;36:2921-8 pubmed 出版商
  433. Narumi K, Hirose T, Sato E, Mori T, Kisu K, Ishikawa M, et al. A functional (pro)renin receptor is expressed in human lymphocytes and monocytes. Am J Physiol Renal Physiol. 2015;308:F487-99 pubmed 出版商
  434. Pastor Clerigues A, Martí Bonmatí E, Milara J, Almudever P, Cortijo J. Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease. PLoS ONE. 2014;9:e115404 pubmed 出版商
  435. Bifsha P, Yang J, Fisher R, Drouin J. Rgs6 is required for adult maintenance of dopaminergic neurons in the ventral substantia nigra. PLoS Genet. 2014;10:e1004863 pubmed 出版商
  436. Girotti M, Lopes F, Preece N, Niculescu Duvaz D, Zambon A, Davies L, et al. Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma. Cancer Cell. 2015;27:85-96 pubmed 出版商
  437. Delloye Bourgeois C, Jacquier A, Charoy C, Reynaud F, Nawabi H, Thoinet K, et al. PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. Nat Neurosci. 2015;18:36-45 pubmed 出版商
  438. Diesenberg K, Beerbaum M, Fink U, Schmieder P, Krauss M. SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR. J Cell Sci. 2015;128:397-407 pubmed 出版商
  439. Bernusso V, Machado Neto J, Pericole F, Vieira K, Duarte A, Traina F, et al. Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells. Biochim Biophys Acta. 2015;1853:388-95 pubmed 出版商
  440. Xu T, Pan Z, Dong M, Yu C, Niu Y. Ferulic acid suppresses activation of hepatic stellate cells through ERK1/2 and Smad signaling pathways in vitro. Biochem Pharmacol. 2015;93:49-58 pubmed 出版商
  441. Tang D, Yu Y, Zhao X, Schachner M, Zhao W. Single chain fragment variable antibodies developed by using as target the 3rd fibronectin type III homologous repeat fragment of human neural cell adhesion molecule L1 promote cell migration and neuritogenesis. Exp Cell Res. 2015;330:336-45 pubmed 出版商
  442. Olayanju A, Copple I, Bryan H, Edge G, Sison R, Wong M, et al. Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2. Free Radic Biol Med. 2015;78:202-12 pubmed 出版商
  443. Giovannini C, Minguzzi M, Baglioni M, Fornari F, Giannone F, Ravaioli M, et al. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. Oncotarget. 2014;5:10607-20 pubmed
  444. Heynen G, Fonfara A, Bernards R. Resistance to targeted cancer drugs through hepatocyte growth factor signaling. Cell Cycle. 2014;13:3808-17 pubmed 出版商
  445. Matsuoka S, Gupta S, Suzuki E, Hiromi Y, Asaoka M. gone early, a novel germline factor, ensures the proper size of the stem cell precursor pool in the Drosophila ovary. PLoS ONE. 2014;9:e113423 pubmed 出版商
  446. Janardhan S, Marks R, Gajewski T. Primary murine CD4+ T cells fail to acquire the ability to produce effector cytokines when active Ras is present during Th1/Th2 differentiation. PLoS ONE. 2014;9:e112831 pubmed 出版商
  447. Huang L, Carney J, Cardona D, Counter C. Decreased tumorigenesis in mice with a Kras point mutation at C118. Nat Commun. 2014;5:5410 pubmed 出版商
  448. Blaabjerg L, Christensen G, Matsumoto M, van der Meulen T, Huising M, Billestrup N, et al. CRFR1 activation protects against cytokine-induced β-cell death. J Mol Endocrinol. 2014;53:417-27 pubmed 出版商
  449. Huertas Martínez J, Rello Varona S, Herrero Martín D, Barrau I, García Monclús S, Sáinz Jaspeado M, et al. Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth. Oncotarget. 2014;5:9744-55 pubmed
  450. Rai S, Tanaka H, Suzuki M, Ogoh H, Taniguchi Y, Morita Y, et al. Clathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cells. PLoS ONE. 2014;9:e109441 pubmed 出版商
  451. Wang Y, Kuramitsu Y, Tokuda K, Baron B, Kitagawa T, Akada J, et al. Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer. PLoS ONE. 2014;9:e109076 pubmed 出版商
  452. Kannike K, Sepp M, Zuccato C, Cattaneo E, Timmusk T. Forkhead transcription factor FOXO3a levels are increased in Huntington disease because of overactivated positive autofeedback loop. J Biol Chem. 2014;289:32845-57 pubmed 出版商
  453. Zhang X, Zhang Q, Tu J, Zhu Y, Yang F, Liu B, et al. Prosurvival NMDA 2A receptor signaling mediates postconditioning neuroprotection in the hippocampus. Hippocampus. 2015;25:286-96 pubmed 出版商
  454. Zhou X, Tao Y, Wang J, Liang C, Wang J, Li H, et al. Roles of FGF-2 and TGF-beta/FGF-2 on differentiation of human mesenchymal stem cells towards nucleus pulposus-like phenotype. Growth Factors. 2015;33:23-30 pubmed 出版商
  455. Charlaftis N, Suddason T, Wu X, Anwar S, Karin M, Gallagher E. The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines. EMBO J. 2014;33:2581-96 pubmed 出版商
  456. Zhu X, Zhao L, Park J, Willingham M, Cheng S. Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation. Neoplasia. 2014;16:757-69 pubmed 出版商
  457. Dou W, Zhang J, Ren G, Ding L, Sun A, Deng C, et al. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation. Int Immunopharmacol. 2014;23:170-8 pubmed 出版商
  458. Pilchova I, Klacanova K, Chomova M, Tatarkova Z, Dobrota D, Racay P. Possible contribution of proteins of Bcl-2 family in neuronal death following transient global brain ischemia. Cell Mol Neurobiol. 2015;35:23-31 pubmed 出版商
  459. Candelaria N, Addanki S, Zheng J, Nguyen Vu T, Karaboga H, Dey P, et al. Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. PLoS ONE. 2014;9:e106289 pubmed 出版商
  460. Tang J, Shen L, Yang Q, Zhang C. Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition. Cell Prolif. 2014;47:427-34 pubmed 出版商
  461. Sa S, Wong L, McCloskey K. Combinatorial fibronectin and laminin signaling promote highly efficient cardiac differentiation of human embryonic stem cells. Biores Open Access. 2014;3:150-61 pubmed 出版商
  462. Han P, Zhou X, Chang N, Xiao C, Yan S, Ren H, et al. Hydrogen peroxide primes heart regeneration with a derepression mechanism. Cell Res. 2014;24:1091-107 pubmed 出版商
  463. Li L, Wu P, Lee J, Li P, Hsieh W, Ho C, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS ONE. 2014;9:e104203 pubmed 出版商
  464. Zhang S, Ren M, Zeng X, He P, Ma X, Qiao S. Leucine stimulates ASCT2 amino acid transporter expression in porcine jejunal epithelial cell line (IPEC-J2) through PI3K/Akt/mTOR and ERK signaling pathways. Amino Acids. 2014;46:2633-42 pubmed 出版商
  465. Watanabe T, Nakamura S, Ono T, Ui S, Yagi S, Kagawa H, et al. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma. Biochem Biophys Res Commun. 2014;451:93-100 pubmed 出版商
  466. Castorina A, Giunta S. Mucin 1 (MUC1) signalling contributes to increase the resistance to cell death in human bronchial epithelial cells exposed to nickel acetate. Biometals. 2014;27:1149-58 pubmed 出版商
  467. Wu T, Ye Y, Min S, Zhu J, Khobahy E, Zhou J, et al. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid. Arthritis Rheumatol. 2014;66:3129-39 pubmed 出版商
  468. Zeldich E, Chen C, Colvin T, Bove Fenderson E, Liang J, Tucker Zhou T, et al. The neuroprotective effect of Klotho is mediated via regulation of members of the redox system. J Biol Chem. 2014;289:24700-15 pubmed 出版商
  469. Kugel C, Hartsough E, Davies M, Setiady Y, Aplin A. Function-blocking ERBB3 antibody inhibits the adaptive response to RAF inhibitor. Cancer Res. 2014;74:4122-32 pubmed 出版商
  470. Kapur N, Qiao X, Paruchuri V, Mackey E, Daly G, Ughreja K, et al. Reducing endoglin activity limits calcineurin and TRPC-6 expression and improves survival in a mouse model of right ventricular pressure overload. J Am Heart Assoc. 2014;3: pubmed 出版商
  471. Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, et al. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Eur J Cancer. 2014;50:2336-50 pubmed 出版商
  472. Ribeiro M, Rosenstock T, Oliveira A, Oliveira C, Rego A. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells. Free Radic Biol Med. 2014;74:129-44 pubmed 出版商
  473. Liu J, Ke F, Xu Z, Liu Z, Zhang L, Yan S, et al. CCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo. PLoS ONE. 2014;9:e101137 pubmed 出版商
  474. Martínez Pinilla E, Reyes Resina I, Oñatibia Astibia A, Zamarbide M, Ricobaraza A, Navarro G, et al. CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum. Exp Neurol. 2014;261:44-52 pubmed 出版商
  475. Chang P, Hung C, Wang S, Tsai P, Shih Y, Chen L, et al. Identification and characterization of two novel spliced genes located in the orf47-orf46-orf45 gene locus of Kaposi's sarcoma-associated herpesvirus. J Virol. 2014;88:10092-109 pubmed 出版商
  476. Rathore K, Cekanova M. Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines. BMC Cancer. 2014;14:465 pubmed 出版商
  477. Ishikawa D, Shimada M, Utsunomiya T, Morine Y, Imura S, Ikemoto T, et al. Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol Hepatol. 2014;29:2032-7 pubmed 出版商
  478. Au Yeung B, Melichar H, Ross J, Cheng D, Zikherman J, Shokat K, et al. Quantitative and temporal requirements revealed for Zap70 catalytic activity during T cell development. Nat Immunol. 2014;15:687-94 pubmed 出版商
  479. Zielniok K, Motyl T, Gajewska M. Functional interactions between 17 ? -estradiol and progesterone regulate autophagy during acini formation by bovine mammary epithelial cells in 3D cultures. Biomed Res Int. 2014;2014:382653 pubmed 出版商
  480. Mena H, Lokajczyk A, Dizier B, Strier S, Voto L, Boisson Vidal C, et al. Acidic preconditioning improves the proangiogenic responses of endothelial colony forming cells. Angiogenesis. 2014;17:867-79 pubmed 出版商
  481. Attarha S, Andersson S, Mints M, Souchelnytskyi S. Mammalian sterile-like 1 kinase inhibits TGF? and EGF?dependent regulation of invasiveness, migration and proliferation of HEC-1-A endometrial cancer cells. Int J Oncol. 2014;45:853-60 pubmed 出版商
  482. Kardos G, Dai M, Robertson G. Growth inhibitory effects of large subunit ribosomal proteins in melanoma. Pigment Cell Melanoma Res. 2014;27:801-12 pubmed 出版商
  483. Jiang Y, Kou Z, Wu T, An W, Zhou R, Wang H, et al. Xist deficiency and disorders of X-inactivation in rabbit embryonic stem cells can be rescued by transcription-factor-mediated conversion. Stem Cells Dev. 2014;23:2283-96 pubmed 出版商
  484. Cazanave S, Wang X, Zhou H, Rahmani M, Grant S, Durrant D, et al. Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis. Cell Death Differ. 2014;21:1303-12 pubmed 出版商
  485. Doughton G, Wei J, Tapon N, Welham M, Chalmers A. Formation of a polarised primitive endoderm layer in embryoid bodies requires fgfr/erk signalling. PLoS ONE. 2014;9:e95434 pubmed 出版商
  486. Ost M, Werner F, Dokas J, Klaus S, Voigt A. Activation of AMPK?2 is not crucial for mitochondrial uncoupling-induced metabolic effects but required to maintain skeletal muscle integrity. PLoS ONE. 2014;9:e94689 pubmed 出版商
  487. Kerdivel G, Boudot A, Habauzit D, Percevault F, Demay F, Pakdel F, et al. Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines. Mol Cell Endocrinol. 2014;390:34-44 pubmed 出版商
  488. Gürtler C, Carty M, Kearney J, Schattgen S, Ding A, Fitzgerald K, et al. SARM regulates CCL5 production in macrophages by promoting the recruitment of transcription factors and RNA polymerase II to the Ccl5 promoter. J Immunol. 2014;192:4821-32 pubmed 出版商
  489. Chen P, Qin L, Zhuang Z, Tellides G, Lax I, Schlessinger J, et al. The docking protein FRS2? is a critical regulator of VEGF receptors signaling. Proc Natl Acad Sci U S A. 2014;111:5514-9 pubmed 出版商
  490. Lamprecht M, Morrison B. GPR30 activation is neither necessary nor sufficient for acute neuroprotection by 17?-estradiol after an ischemic injury in organotypic hippocampal slice cultures. Brain Res. 2014;1563:131-7 pubmed 出版商
  491. Guerra M, Wauson E, McGlynn K, Cobb M. Muscarinic control of MIN6 pancreatic ? cells is enhanced by impaired amino acid signaling. J Biol Chem. 2014;289:14370-9 pubmed 出版商
  492. Bölck B, Ibrahim M, Steinritz D, Morguet C, Dühr S, Suhr F, et al. Detection of key enzymes, free radical reaction products and activated signaling molecules as biomarkers of cell damage induced by benzo[a]pyrene in human keratinocytes. Toxicol In Vitro. 2014;28:875-84 pubmed 出版商
  493. Maier P, Zemoura K, Acu a M, Y venes G, Zeilhofer H, Benke D. Ischemia-like oxygen and glucose deprivation mediates down-regulation of cell surface ?-aminobutyric acidB receptors via the endoplasmic reticulum (ER) stress-induced transcription factor CCAAT/enhancer-binding protein (C/EBP)-homologous protein (CH. J Biol Chem. 2014;289:12896-907 pubmed 出版商
  494. Anchan D, Clark S, Pollard K, Vasudevan N. GPR30 activation decreases anxiety in the open field test but not in the elevated plus maze test in female mice. Brain Behav. 2014;4:51-9 pubmed 出版商
  495. Singel S, Batten K, Cornelius C, Jia G, Fasciani G, Barron S, et al. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways. Breast Cancer Res. 2014;16:R28 pubmed 出版商
  496. Tsai Y, Wang C, Leung P, Lin K, Chio C, Hu C, et al. Extracellular signal-regulated kinase 1/2 is involved in a tamoxifen neuroprotective effect in a lateral fluid percussion injury rat model. J Surg Res. 2014;189:106-16 pubmed 出版商
  497. Wei N, Chu E, Wipf P, Schmitz J. Protein kinase d as a potential chemotherapeutic target for colorectal cancer. Mol Cancer Ther. 2014;13:1130-41 pubmed 出版商
  498. Yu P, Laird A, Du X, Wu J, Won K, Yamaguchi K, et al. Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway. Mol Cancer Ther. 2014;13:1078-91 pubmed 出版商
  499. Wang Q, Shen B, Chen L, Zheng P, Feng H, Hao Q, et al. Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis. Oncogene. 2015;34:1006-18 pubmed 出版商
  500. Chapnick D, Liu X. Leader cell positioning drives wound-directed collective migration in TGF?-stimulated epithelial sheets. Mol Biol Cell. 2014;25:1586-93 pubmed 出版商
  501. Bokobza S, Jiang Y, Weber A, Devery A, Ryan A. Short-course treatment with gefitinib enhances curative potential of radiation therapy in a mouse model of human non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014;88:947-54 pubmed 出版商
  502. Cheng C, Lin J, Su S, Tang N, Kao S, Hsieh C. Electroacupuncture-like stimulation at Baihui and Dazhui acupoints exerts neuroprotective effects through activation of the brain-derived neurotrophic factor-mediated MEK1/2/ERK1/2/p90RSK/bad signaling pathway in mild transient focal cerebral ischemi. BMC Complement Altern Med. 2014;14:92 pubmed 出版商
  503. Fernandez Estevez M, Casarejos M, Lopez Sendon J, Garcia Caldentey J, Ruiz C, Gomez A, et al. Trehalose reverses cell malfunction in fibroblasts from normal and Huntington's disease patients caused by proteosome inhibition. PLoS ONE. 2014;9:e90202 pubmed 出版商
  504. Okada T, Nitta T, Kaji K, Takashima A, Oda H, Tamehiro N, et al. Differential function of Themis CABIT domains during T cell development. PLoS ONE. 2014;9:e89115 pubmed 出版商
  505. Son J, Jeong H, Kim H, Kim Y, Lee E, Lee H, et al. Pelargonidin attenuates PDGF-BB-induced aortic smooth muscle cell proliferation and migration by direct inhibition of focal adhesion kinase. Biochem Pharmacol. 2014;89:236-45 pubmed 出版商
  506. Ihunnah C, Wada T, Philips B, Ravuri S, Gibbs R, Kirisci L, et al. Estrogen sulfotransferase/SULT1E1 promotes human adipogenesis. Mol Cell Biol. 2014;34:1682-94 pubmed 出版商
  507. Okada N, Lin C, Ribeiro M, Biton A, Lai G, He X, et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev. 2014;28:438-50 pubmed 出版商
  508. Wang Y, Kuramitsu Y, Tokuda K, Okada F, Baron B, Akada J, et al. Proteomic analysis indicates that overexpression and nuclear translocation of lactoylglutathione lyase (GLO1) is associated with tumor progression in murine fibrosarcoma. Electrophoresis. 2014;35:2195-202 pubmed 出版商
  509. Feng C, Zhang Y, Yin J, Li J, Abounader R, Zuo Z. Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma. Neuro Oncol. 2014;16:1078-85 pubmed 出版商
  510. Milara J, Peiró T, Serrano A, Guijarro R, Zaragozá C, Tenor H, et al. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD. Pulm Pharmacol Ther. 2014;28:138-48 pubmed 出版商
  511. Park E, Kim B, Lee E, Chang E, Kim D, Choi S, et al. Targeting of receptor for advanced glycation end products suppresses cyst growth in polycystic kidney disease. J Biol Chem. 2014;289:9254-62 pubmed 出版商
  512. Lee M, Smith S, Murray S, Pham L, Minoo P, Nielsen H. Dihydrotestosterone potentiates EGF-induced ERK activation by inducing SRC in fetal lung fibroblasts. Am J Respir Cell Mol Biol. 2014;51:114-24 pubmed 出版商
  513. Jin Y, Wi H, Choi M, Hong S, Bae Y. Regulation of anti-inflammatory cytokines IL-10 and TGF-? in mouse dendritic cells through treatment with Clonorchis sinensis crude antigen. Exp Mol Med. 2014;46:e74 pubmed 出版商
  514. Gámez M, Calvo M, Selgas M, García M, Erler K, Böhm V, et al. Effect of E-beam treatment on the chemistry and on the antioxidant activity of lycopene from dry tomato peel and tomato powder. J Agric Food Chem. 2014;62:1557-63 pubmed 出版商
  515. Joannes A, Grelet S, Duca L, Gilles C, Kileztky C, Dalstein V, et al. Fhit regulates EMT targets through an EGFR/Src/ERK/Slug signaling axis in human bronchial cells. Mol Cancer Res. 2014;12:775-83 pubmed 出版商
  516. Valdez Magaña G, Rodriguez A, Zhang H, Webb R, Alberio R. Paracrine effects of embryo-derived FGF4 and BMP4 during pig trophoblast elongation. Dev Biol. 2014;387:15-27 pubmed 出版商
  517. Turner M, Cronin J, Healey G, Sheldon I. Epithelial and stromal cells of bovine endometrium have roles in innate immunity and initiate inflammatory responses to bacterial lipopeptides in vitro via Toll-like receptors TLR2, TLR1, and TLR6. Endocrinology. 2014;155:1453-65 pubmed 出版商
  518. Murcia Belmonte V, Medina Rodríguez E, Bribian A, De Castro F, Esteban P. ERK1/2 signaling is essential for the chemoattraction exerted by human FGF2 and human anosmin-1 on newborn rat and mouse OPCs via FGFR1. Glia. 2014;62:374-86 pubmed 出版商
  519. Xu C, Chen H, Wang X, Gao J, Che Y, Li Y, et al. S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling. J Biol Chem. 2014;289:827-37 pubmed 出版商
  520. Wang J, Chen J, Miller D, Li W. Synergistic combination of novel tubulin inhibitor ABI-274 and vemurafenib overcome vemurafenib acquired resistance in BRAFV600E melanoma. Mol Cancer Ther. 2014;13:16-26 pubmed 出版商
  521. Castorina A, Scuderi S, D Amico A, Drago F, D Agata V. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways. Exp Cell Res. 2014;322:108-21 pubmed 出版商
  522. Zaganjor E, Osborne J, Weil L, Díaz Martínez L, Gonzales J, Singel S, et al. Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells. Oncogene. 2014;33:5457-66 pubmed 出版商
  523. Udagawa T, Farny N, Jakovcevski M, Kaphzan H, Alarcon J, Anilkumar S, et al. Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology. Nat Med. 2013;19:1473-7 pubmed 出版商
  524. Lu J, Chang Y, Wang C, Lin Y, Lin C, Wu Z. Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor ?-induced lipolysis in 3T3-L1 adipocytes. PLoS ONE. 2013;8:e71517 pubmed 出版商
  525. O Brien M, Carbin S, Morrison J, Smith T. Decreased myometrial p160 ROCK-1 expression in obese women at term pregnancy. Reprod Biol Endocrinol. 2013;11:79 pubmed 出版商
  526. Kucherlapati M, Esfahani S, Habibollahi P, Wang J, Still E, Bronson R, et al. Genotype directed therapy in murine mismatch repair deficient tumors. PLoS ONE. 2013;8:e68817 pubmed 出版商
  527. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed 出版商
  528. Li Y, Takahashi M, Stork P. Ras-mutant cancer cells display B-Raf binding to Ras that activates extracellular signal-regulated kinase and is inhibited by protein kinase A phosphorylation. J Biol Chem. 2013;288:27646-57 pubmed 出版商
  529. Mao X, Hütt Cabezas M, Orr B, Weingart M, Taylor I, Rajan A, et al. LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program. Oncotarget. 2013;4:1050-64 pubmed
  530. Beckham T, Cheng J, Lu P, Shao Y, Troyer D, Lance R, et al. Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling. Oncogenesis. 2013;2:e49 pubmed 出版商
  531. Henderson Y, Toro Serra R, Chen Y, Ryu J, Frederick M, Zhou G, et al. Src inhibitors in suppression of papillary thyroid carcinoma growth. Head Neck. 2014;36:375-84 pubmed 出版商
  532. Ahnstedt H, Cao L, Krause D, Warfvinge K, Saveland H, Nilsson O, et al. Male-female differences in upregulation of vasoconstrictor responses in human cerebral arteries. PLoS ONE. 2013;8:e62698 pubmed 出版商
  533. Lin S, Hoffmann K, Xiao Z, Jin N, Galli U, Mohr E, et al. MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma. Cancer Cell Int. 2013;13:3 pubmed 出版商
  534. Cieslik K, Trial J, Carlson S, Taffet G, Entman M. Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels. FASEB J. 2013;27:1761-71 pubmed 出版商
  535. Slowik A, Merres J, Elfgen A, Jansen S, Mohr F, Wruck C, et al. Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE)--and amyloid beta 1-42-induced signal transduction in glial cells. Mol Neurodegener. 2012;7:55 pubmed 出版商
  536. Brandenburg L, Jansen S, Albrecht L, Merres J, Gerber J, Pufe T, et al. CpG oligodeoxynucleotides induce the expression of the antimicrobial peptide cathelicidin in glial cells. J Neuroimmunol. 2013;255:18-31 pubmed 出版商
  537. Kim J, Hwang I, Choi S, Lee H, Lee Y, Goo J, et al. Aqueous extract of Liriope platyphylla, a traditional Chinese medicine, significantly inhibits abdominal fat accumulation and improves glucose regulation in OLETF type II diabetes model rats. Lab Anim Res. 2012;28:181-91 pubmed 出版商
  538. Turco M, Furia L, Dietze A, Fernandez Diaz L, Ronzoni S, Sciullo A, et al. Cellular heterogeneity during embryonic stem cell differentiation to epiblast stem cells is revealed by the ShcD/RaLP adaptor protein. Stem Cells. 2012;30:2423-36 pubmed 出版商
  539. Iio W, Matsukawa N, Tsukahara T, Toyoda A. The effects of oral taurine administration on behavior and hippocampal signal transduction in rats. Amino Acids. 2012;43:2037-46 pubmed 出版商
  540. Lemire B, Debigare R, Dubé A, Thériault M, Cote C, Maltais F. MAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease. J Appl Physiol (1985). 2012;113:159-66 pubmed 出版商
  541. Machado Neto J, Favaro P, Lazarini M, Costa F, Olalla Saad S, Traina F. Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells. Biochim Biophys Acta. 2011;1813:1404-11 pubmed 出版商
  542. Urbanet R, Pilon C, Giorgino F, Vettor R, Fallo F. Insulin signaling in adipose tissue of patients with primary aldosteronism. J Endocrinol Invest. 2011;34:86-9 pubmed
  543. Chang J, Adams M, Clifton M, Liao M, Brooks J, Hasdemir B, et al. Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2. Am J Physiol Gastrointest Liver Physiol. 2011;300:G884-94 pubmed 出版商
  544. Modi H, Li L, Chu S, Rossi J, Yee J, Bhatia R. Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells. Leukemia. 2011;25:305-12 pubmed 出版商
  545. Kunath T, Saba El Leil M, Almousailleakh M, Wray J, Meloche S, Smith A. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development. 2007;134:2895-902 pubmed
  546. Zha Y, Marks R, Ho A, Peterson A, Janardhan S, Brown I, et al. T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha. Nat Immunol. 2006;7:1166-73 pubmed
  547. Zhu M, Feng J, Lucchinetti E, Fischer G, Xu L, Pedrazzini T, et al. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res. 2006;72:152-62 pubmed
  548. Lo I, Shih J, Jiang M. Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. J Biomed Sci. 2005;12:377-88 pubmed
  549. Tsai M, Jiang M. Extracellular signal-regulated kinase1/2 in contraction of vascular smooth muscle. Life Sci. 2005;76:877-88 pubmed
  550. Usui S, Sugimoto N, Takuwa N, Sakagami S, Takata S, Kaneko S, et al. Blood lipid mediator sphingosine 1-phosphate potently stimulates platelet-derived growth factor-A and -B chain expression through S1P1-Gi-Ras-MAPK-dependent induction of Kruppel-like factor 5. J Biol Chem. 2004;279:12300-11 pubmed
  551. Hernandez M, Barrero M, Crespo M, Nieto M. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein. J Neurochem. 2000;75:1575-82 pubmed
  552. Chan E, Stang S, Bottorff D, Stone J. Hypothermic stress leads to activation of Ras-Erk signaling. J Clin Invest. 1999;103:1337-44 pubmed
  553. Korneyev A. Stress-induced tau phosphorylation in mouse strains with different brain Erk 1 + 2 immunoreactivity. Neurochem Res. 1998;23:1539-43 pubmed
  554. Webb C, Van Aelst L, Wigler M, Vande Woude G. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci U S A. 1998;95:8773-8 pubmed
  555. Duesbery N, Webb C, Leppla S, Gordon V, Klimpel K, Copeland T, et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 1998;280:734-7 pubmed
  556. Hidari K, Weyrich A, Zimmerman G, McEver R. Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J Biol Chem. 1997;272:28750-6 pubmed